Cover Page
Cover Page - shares | 6 Months Ended | |
Dec. 31, 2022 | Jan. 27, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-34249 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 95-0725980 | |
Entity Address, Postal Zip Code | 76262 | |
Entity Address, State or Province | TX | |
Entity Address, City or Town | Northlake | |
Entity Address, Address Line One | 1912 Farmer Brothers Drive | |
Local Phone Number | 549-6600 | |
City Area Code | 682 | |
Title of 12(b) Security | Common Stock, par value $1.00 per share | |
Trading Symbol | FARM | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 19,953,781 | |
Entity Registrant Name | FARMER BROTHERS CO | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Document Fiscal Period Focus | Q2 | |
Entity Central Index Key | 0000034563 | |
Document Fiscal Year Focus | 2023 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 17,624 | $ 9,819 |
Restricted cash | 2,316 | 175 |
Accounts receivable, net of allowance for credit losses of $190 and $195, respectively | 50,313 | 46,935 |
Inventories | 83,537 | 99,618 |
Short-term derivative assets | 1,836 | 3,022 |
Prepaid expenses | 4,480 | 4,491 |
Assets held for sale | 110 | 1,032 |
Total current assets | 160,216 | 165,092 |
Property, plant and equipment, net | 133,726 | 138,150 |
Intangible assets, net | 14,678 | 15,863 |
Right-of-use operating lease assets | 27,341 | 27,957 |
Other assets | 3,033 | 3,009 |
Total assets | 338,994 | 350,071 |
Current liabilities: | ||
Accounts payable | 62,616 | 52,877 |
Accrued payroll expenses | 8,925 | 14,761 |
Right-of-use operating lease liabilities - current | 7,974 | 7,721 |
Term loan - current | 3,133 | 3,800 |
Short term derivative liability | 5,352 | 2,349 |
Other current liabilities | 5,626 | 6,095 |
Total current liabilities | 93,626 | 87,603 |
Long-term borrowings under revolving credit facility | 67,000 | 63,000 |
Term loan - noncurrent | 42,131 | 40,123 |
Accrued pension liabilities | 28,513 | 28,540 |
Accrued postretirement benefits | 807 | 787 |
Accrued workers’ compensation liabilities | 2,704 | 3,169 |
Right-of-use operating lease liabilities - noncurrent | 19,938 | 20,762 |
Other long-term liabilities | 1,337 | 1,339 |
Total liabilities | 256,056 | 245,323 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $1.00 par value, 500,000 shares authorized; Series A Convertible Participating Cumulative Perpetual Preferred Stock, 21,000 shares authorized; no shares outstanding as of December 31, 2022 and 14,700 shares issued and outstanding as of June 30, 2022; liquidation preference of $17,346 as of June 30, 2022 | 0 | 15 |
Common stock, $1.00 par value, 50,000,000 shares authorized; 19,681,943 and 18,464,966 shares issued and outstanding as of December 31, 2022 and June 30, 2022, respectively | 19,683 | 18,466 |
Additional paid-in capital | 74,094 | 71,997 |
Retained earnings | 31,719 | 52,701 |
Accumulated other comprehensive loss | (42,558) | (38,431) |
Total stockholders’ equity | 82,938 | 104,748 |
Total liabilities and stockholders’ equity | $ 338,994 | $ 350,071 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Accounts Receivable, Allowance for Credit Loss, Current | $ 190 | $ 195 |
Preferred stock, par value (in US$ per share) | $ 1 | $ 1 |
Preferred Stock, Shares Authorized (in shares) | 500,000 | 500,000 |
Preferred Stock, Shares Outstanding | 0 | |
Preferred stock, issued (in shares) | 0 | |
Liquidation preference | $ 17,346 | |
Common stock, par value (in US$ per share) | $ 1 | $ 1 |
Common stock, shares authorized (in shares) | 50,000,000 | |
Common stock, shares issued (in shares) | 19,681,943 | 18,464,966 |
Common stock, shares outstanding (in shares) | 19,681,943 | 18,464,966 |
Preferred Class A | ||
Preferred Stock, Shares Authorized (in shares) | 21,000 | 21,000 |
Preferred Stock, Shares Outstanding | 0 | 14,700 |
Preferred stock, issued (in shares) | 14,700 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | ||||
Net sales | $ 132,692 | $ 118,445 | $ 254,073 | $ 226,807 |
Cost of goods sold | 102,303 | 83,451 | 197,086 | 160,359 |
Gross profit | 30,389 | 34,994 | 56,987 | 66,448 |
Selling expenses | 27,220 | 28,019 | 54,811 | 54,028 |
General and administrative expenses | 9,832 | 11,394 | 20,319 | 23,201 |
Net loss (gains) from sales of assets | 55 | 153 | (7,127) | (4,429) |
Operating expenses | 37,107 | 39,566 | 68,003 | 72,800 |
Loss from operations | (6,718) | (4,572) | (11,016) | (6,352) |
Other (expense) income: | ||||
Interest expense | (3,580) | (2,489) | (8,221) | (5,515) |
Other, net | (3,270) | 1,767 | (1,662) | 4,211 |
Total other expense | (6,850) | (722) | (9,883) | (1,304) |
Loss before taxes | (13,568) | (5,294) | (20,899) | (7,656) |
Income tax expense | 40 | 126 | 83 | 188 |
Net loss | (13,608) | (5,420) | (20,982) | (7,844) |
Less: Cumulative preferred dividends, undeclared and unpaid | 0 | 148 | 0 | 295 |
Undistributed net loss available to common stockholders | $ (13,608) | $ (5,568) | $ (20,982) | $ (8,139) |
Net loss per common share - basic (in US$ per share) | $ (0.73) | $ (0.31) | $ (1.09) | $ (0.45) |
Net loss per common share - diluted (in US$ per share) | $ (0.73) | $ (0.31) | $ (1.09) | $ (0.45) |
Weighted average common shares outstanding - basic (in shares) | 18,723,957 | 18,106,151 | 19,243,707 | 18,034,658 |
Weighted average common shares outstanding—diluted (in shares) | 18,723,957 | 18,106,151 | 19,243,707 | 18,034,658 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (13,608) | $ (5,420) | $ (20,982) | $ (7,844) |
Other comprehensive (loss) income: | ||||
Unrealized (losses) gains on derivatives designated as cash flow hedges | (2,284) | 5,132 | (2,812) | 10,991 |
Gains on derivatives designated as cash flow hedges reclassified to cost of goods sold | (600) | (3,712) | (1,881) | (5,632) |
Losses on derivative instruments undesignated as cash flow hedges reclassified to interest expense, net of tax | 279 | 308 | 566 | 622 |
Total comprehensive loss, net of tax | $ (16,213) | $ (3,692) | $ (25,109) | $ (1,863) |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) | Total | Preferred Shares | Common Shares | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning Balance (in shares) at Jun. 30, 2021 | 14,700,000 | 17,852,793,000 | ||||
Accumulated other comprehensive income beginning balance at Jun. 30, 2021 | $ 104,959,000 | $ 15,000 | $ 17,853,000 | $ 66,109,000 | $ 66,311,000 | $ (45,329,000) |
Net income (loss) | (2,424,000) | (2,424,000) | ||||
Cash flow hedges, net of taxes | 4,253,000 | 4,253,000 | ||||
ESOP and 401(k) compensation expense, including reclassifications (in shares) | 51,597,000 | |||||
ESOP and 401(k) compensation expense, including reclassifications | 671,000 | $ 52,000 | 619,000 | |||
Share-based compensation | 721,000 | 721,000 | ||||
Issuance of common stock and stock option exercises (in shares) | 94,407,000 | |||||
Issuance of common stock and stock option exercises | 0 | $ 94,000 | (94,000) | |||
Conversion and cancellation of preferred shares | (147,000) | (147,000) | ||||
Ending Balance (in shares) at Sep. 30, 2021 | 14,700,000 | 17,998,797,000 | ||||
Accumulated other comprehensive income ending balance at Sep. 30, 2021 | 108,033,000 | $ 15,000 | $ 17,999,000 | 67,355,000 | 63,740,000 | (41,076,000) |
Beginning Balance (in shares) at Jun. 30, 2021 | 14,700,000 | 17,852,793,000 | ||||
Accumulated other comprehensive income beginning balance at Jun. 30, 2021 | 104,959,000 | $ 15,000 | $ 17,853,000 | 66,109,000 | 66,311,000 | (45,329,000) |
Net income (loss) | (7,844,000) | |||||
Ending Balance (in shares) at Dec. 31, 2021 | 14,700,000 | 18,210,526,000 | ||||
Accumulated other comprehensive income ending balance at Dec. 31, 2021 | 105,310,000 | $ 15,000 | $ 18,212,000 | 68,259,000 | 58,172,000 | (39,348,000) |
Beginning Balance (in shares) at Sep. 30, 2021 | 14,700,000 | 17,998,797,000 | ||||
Accumulated other comprehensive income beginning balance at Sep. 30, 2021 | 108,033,000 | $ 15,000 | $ 17,999,000 | 67,355,000 | 63,740,000 | (41,076,000) |
Net income (loss) | (5,420,000) | (5,420,000) | ||||
Cash flow hedges, net of taxes | 1,728,000 | 1,728,000 | ||||
ESOP and 401(k) compensation expense, including reclassifications (in shares) | 82,437,000 | |||||
ESOP and 401(k) compensation expense, including reclassifications | 748,000 | $ 84,000 | 664,000 | |||
Share-based compensation | 858,000 | 858,000 | ||||
Issuance of common stock and stock option exercises (in shares) | 129,292,000 | |||||
Issuance of common stock and stock option exercises | (489,000) | $ 129,000 | (618,000) | |||
Conversion and cancellation of preferred shares | (148,000) | (148,000) | ||||
Ending Balance (in shares) at Dec. 31, 2021 | 14,700,000 | 18,210,526,000 | ||||
Accumulated other comprehensive income ending balance at Dec. 31, 2021 | 105,310,000 | $ 15,000 | $ 18,212,000 | 68,259,000 | 58,172,000 | (39,348,000) |
Beginning Balance (in shares) at Jun. 30, 2022 | 14,700,000 | 18,464,966,000 | ||||
Accumulated other comprehensive income beginning balance at Jun. 30, 2022 | 104,748,000 | $ 15,000 | $ 18,466,000 | 71,997,000 | 52,701,000 | (38,431,000) |
Net income (loss) | (7,374,000) | (7,374,000) | ||||
Cash flow hedges, net of taxes | (1,521,000) | (1,521,000) | ||||
ESOP and 401(k) compensation expense, including reclassifications (in shares) | 257,052,000 | |||||
ESOP and 401(k) compensation expense, including reclassifications | 1,197,000 | $ 257,000 | 940,000 | |||
Share-based compensation | 1,165,000 | 1,165,000 | ||||
Issuance of common stock and stock option exercises (in shares) | 158,744,000 | |||||
Issuance of common stock and stock option exercises | 0 | $ 159,000 | (159,000) | |||
Conversion and cancellation of preferred shares (shares) | 14,700,000 | 399,208,000 | ||||
Conversion and cancellation of preferred shares | (1,366,000) | $ (15,000) | $ 399,000 | (1,750,000) | ||
Ending Balance (in shares) at Sep. 30, 2022 | 0 | 19,279,970,000 | ||||
Accumulated other comprehensive income ending balance at Sep. 30, 2022 | 96,849,000 | $ 0 | $ 19,281,000 | 72,193,000 | 45,327,000 | (39,952,000) |
Beginning Balance (in shares) at Jun. 30, 2022 | 14,700,000 | 18,464,966,000 | ||||
Accumulated other comprehensive income beginning balance at Jun. 30, 2022 | 104,748,000 | $ 15,000 | $ 18,466,000 | 71,997,000 | 52,701,000 | (38,431,000) |
Net income (loss) | (20,982,000) | |||||
Ending Balance (in shares) at Dec. 31, 2022 | 0 | 19,681,943,000 | ||||
Accumulated other comprehensive income ending balance at Dec. 31, 2022 | 82,938,000 | $ 0 | $ 19,683,000 | 74,094,000 | 31,719,000 | (42,558,000) |
Beginning Balance (in shares) at Sep. 30, 2022 | 0 | 19,279,970,000 | ||||
Accumulated other comprehensive income beginning balance at Sep. 30, 2022 | 96,849,000 | $ 0 | $ 19,281,000 | 72,193,000 | 45,327,000 | (39,952,000) |
Net income (loss) | (13,608,000) | (13,608,000) | ||||
Cash flow hedges, net of taxes | (2,606,000) | (2,606,000) | ||||
ESOP and 401(k) compensation expense, including reclassifications (in shares) | 264,712,000 | |||||
ESOP and 401(k) compensation expense, including reclassifications | 1,324,000 | $ 265,000 | 1,059,000 | |||
Share-based compensation | 979,000 | 979,000 | ||||
Issuance of common stock and stock option exercises (in shares) | 137,261,000 | |||||
Issuance of common stock and stock option exercises | 0 | $ 137,000 | (137,000) | |||
Ending Balance (in shares) at Dec. 31, 2022 | 0 | 19,681,943,000 | ||||
Accumulated other comprehensive income ending balance at Dec. 31, 2022 | $ 82,938,000 | $ 0 | $ 19,683,000 | $ 74,094,000 | $ 31,719,000 | $ (42,558,000) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities: | ||
Net loss | $ (20,982,000) | $ (7,844,000) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 11,316,000 | 12,328,000 |
Gain on settlement related to Boyd's acquisition | (1,917,000) | 0 |
Net gains from sales of assets | (7,127,000) | (4,429,000) |
Net loss (gains) on derivatives instruments | 2,074,000 | (7,952,000) |
401(k), ESOP and share-based compensation expense | 4,665,000 | 2,507,000 |
Provision for credit losses | 211,000 | 301,000 |
Change in operating assets and liabilities: | ||
Accounts receivable | (3,589,000) | (8,458,000) |
Inventories | 16,081,000 | (11,634,000) |
Derivative (liabilities) assets, net | (1,668,000) | 8,201,000 |
Other assets | (219,000) | 2,273,000 |
Accounts payable | 9,877,000 | 8,237,000 |
Accrued expenses and other | (5,159,000) | (2,125,000) |
Net cash provided by (used in) operating activities | 3,563,000 | (8,595,000) |
Cash flows from investing activities: | ||
Purchases of property, plant and equipment | (7,714,000) | (5,887,000) |
Proceeds from sales of property, plant and equipment | 9,933,000 | 8,175,000 |
Net cash provided by investing activities | 2,219,000 | 2,288,000 |
Cash flows from financing activities: | ||
Proceeds from Credit Facilities | 54,000,000 | 4,000,000 |
Repayments on Credit Facilities | (49,383,000) | (4,000,000) |
Payments of finance lease obligations | (96,000) | (23,000) |
Payment of financing costs | (357,000) | (309,000) |
Net cash provided by (used in) financing activities | 4,164,000 | (332,000) |
Net increase (decrease) in cash and cash equivalents and restricted cash | 9,946,000 | (6,639,000) |
Cash and cash equivalents and restricted cash at beginning of period | 9,994,000 | 10,438,000 |
Cash and cash equivalents and restricted cash at end of period | 19,940,000 | 3,799,000 |
Supplemental disclosure of non-cash investing and financing activities: | ||
Right-of-use assets obtained in exchange for new operating lease liabilities | 2,965,000 | 4,892,000 |
Non cash additions to property, plant and equipment | 522,000 | 134,000 |
Non cash additions to property, plant and equipment | 138,000 | 406,000 |
Cumulative preferred dividends, undeclared and unpaid | $ 0 | $ 295,000 |
Introduction and Basis of Prese
Introduction and Basis of Presentation | 6 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Introduction and Basis of Presentation | Note 1. Introduction and Basis of Presentation Farmer Bros. Co., a Delaware corporation (including its consolidated subsidiaries unless the context otherwise requires, the “Company”), is a leading coffee roaster, wholesaler, equipment servicer and distributor of coffee, tea, and other allied products manufactured under our owned brands, as well as under private labels on behalf of certain customers. Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial data have been included. Operating results for the six months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2023. The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the Securities and Exchange Commission (the “SEC”) on September 2, 2022, and the Form 10-K/A filed on October 27, 2022 (the “2022 Form 10-K”). Principles of Consolidation The consolidated financial statements include the accounts of the Company and its direct and indirect wholly owned subsidiaries FBC Finance Company, a California corporation, Coffee Bean Holding Co., Inc., a Delaware corporation and, the parent company of Coffee Bean International, Inc., an Oregon corporation, China Mist Brands, Inc., a Delaware corporation, and Boyd Assets Co., a Delaware corporation. All intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company reviews its estimates on an ongoing basis using currently available information. Changes in facts and circumstances may result in revised estimates and actual results may differ from those estimates. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2. Summary of Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, see Note 2, “ Summary of Significant Accounting Policies, ” in the Notes to Consolidated Financial Statements in the 2022 Form 10-K. During the six months ended December 31, 2022, there were no significant updates made to the Company’s significant accounting policies. Cash Equivalents At December 31, 2022, we had $17.6 million of unrestricted cash and cash equivalents and $2.3 million in restricted cash on deposit in broker accounts to satisfy margin requirements associated with certain coffee-related derivative instruments resulting from a decline in the “C” market price of green coffee during the three months ended December 31, 2022. Further changes in commodity prices and the number of coffee-related derivative instruments held could have a significant impact on cash deposit requirements under our broker and counterparty agreements and may adversely affect our liquidity. At June 30, 2022, none of the cash in the Company’s coffee-related derivative margin accounts was restricted. Further changes in commodity prices and the number of coffee-related derivative instruments held could have a significant impact on cash deposit requirements under certain of the Company's broker and counterparty agreements. Concentration of Credit Risk At December 31, 2022 and June 30, 2022, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits), derivative instruments and trade receivables. The Company does not have any credit-risk related contingent features that would require it to post additional collateral in support of its net derivative asset positions. Approximately 36% and 35% of the Company’s accounts receivable balance was with five customers at December 31, 2022 and June 30, 2022, respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The accounts receivables are generally short-term and all estimated credit losses have been appropriately considered in establishing the allowance for credit losses. Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (the “FASB”). ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its consolidated financial statements. The following table provides a brief description of the recent ASUs applicable to the Company: Standard Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2020, the FASB issued ASU No. 2020-04, “Facilitation of the Effect of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) The London Interbank Offered Rate (LIBOR) is being discontinued between December 2021 and June 2023. The Company has not entered into any new contracts after December 31, 2021. With the overnight, 1-month, 3-month, 6-month and 12-month USD LIBOR rates being published through June 30, 2023, we will continue to leverage these for the existing contracts. ASU 2020-04 provides temporary optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the transition from LIBOR to alternative reference rate. Issuance date of March 12, 2020 through December 31, 2024. The Company does not anticipate any material impacts on its consolidated financial statements. |
Leases (Notes)
Leases (Notes) | 6 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Note 3. Leases The Company has entered into leases for building facilities, vehicles and other equipment. The Company’s leases have remaining contractual terms through January 31, 2030, some of which have options to extend the lease for up to 10 years. For purposes of calculating operating lease liabilities, lease terms are deemed not to include options to extend the lease renewal until it is reasonably certain that the Company will exercise that option. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Operating lease expense $ 1,986 $ 1,888 $ 3,946 $ 3,670 Finance lease expense: Amortization of finance lease assets 41 41 82 82 Interest on finance lease liabilities 9 11 18 23 Total lease expense $ 2,036 $ 1,940 $ 4,046 $ 3,775 Maturities of lease liabilities are as follows: December 31, 2022 (In thousands) Operating Leases Finance Leases 2023 $ 4,001 $ 96 2024 7,829 193 2025 6,650 193 2026 5,567 96 2027 4,127 — Thereafter 4,008 — Total lease payments 32,182 578 Less: interest (4,270) (54) Total lease obligations $ 27,912 $ 524 Lease term and discount rate: December 31, 2022 June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 6.3 6.3 Finance lease 3.0 3.5 Weighted-average discount rate: Operating lease 6.00 % 5.69 % Finance lease 6.50 % 6.50 % Other Information: Six Months Ended December 31, (In thousands) 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,882 $ 3,351 Operating cash flows from finance leases 18 73 Financing cash flows from finance leases 96 23 |
Leases | Note 3. Leases The Company has entered into leases for building facilities, vehicles and other equipment. The Company’s leases have remaining contractual terms through January 31, 2030, some of which have options to extend the lease for up to 10 years. For purposes of calculating operating lease liabilities, lease terms are deemed not to include options to extend the lease renewal until it is reasonably certain that the Company will exercise that option. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Operating lease expense $ 1,986 $ 1,888 $ 3,946 $ 3,670 Finance lease expense: Amortization of finance lease assets 41 41 82 82 Interest on finance lease liabilities 9 11 18 23 Total lease expense $ 2,036 $ 1,940 $ 4,046 $ 3,775 Maturities of lease liabilities are as follows: December 31, 2022 (In thousands) Operating Leases Finance Leases 2023 $ 4,001 $ 96 2024 7,829 193 2025 6,650 193 2026 5,567 96 2027 4,127 — Thereafter 4,008 — Total lease payments 32,182 578 Less: interest (4,270) (54) Total lease obligations $ 27,912 $ 524 Lease term and discount rate: December 31, 2022 June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 6.3 6.3 Finance lease 3.0 3.5 Weighted-average discount rate: Operating lease 6.00 % 5.69 % Finance lease 6.50 % 6.50 % Other Information: Six Months Ended December 31, (In thousands) 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,882 $ 3,351 Operating cash flows from finance leases 18 73 Financing cash flows from finance leases 96 23 |
Derivative Instruments
Derivative Instruments | 6 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Note 4. Derivative Instruments Derivative Instruments Held Coffee-Related Derivative Instruments The Company is exposed to commodity price risk associated with its price to be fixed green coffee purchase contracts, which are described further in Note 2, “ Summary of Significant Accounting Policies ,” in the Notes to the Consolidated Financial Statements in the 2022 Form 10-K. The Company utilizes forward and option contracts to manage exposure to the variability in expected future cash flows from forecasted purchases of green coffee attributable to commodity price risk. Certain of these coffee-related derivative instruments utilized for risk management purposes have been designated as cash flow hedges, while other coffee-related derivative instruments have not been designated as cash flow hedges or do not qualify for hedge accounting despite hedging the Company’s future cash flows on an economic basis. The following table summarizes the notional volumes for the coffee-related derivative instruments held by the Company at December 31, 2022 and June 30, 2022: (In thousands) December 31, 2022 June 30, 2022 Derivative instruments designated as cash flow hedges: Long coffee pounds 3,638 4,200 Derivative instruments not designated as cash flow hedges: Long coffee pounds 8,377 516 Short coffee pounds (4,688) — Total 7,327 4,716 Coffee-related derivative instruments designated as cash flow hedges outstanding as of December 31, 2022 will expire within 12 months. At December 31, 2022 and June 30, 2022 approximately 50% and 89%, respectively, of the Company's outstanding coffee-related derivative instruments were designated as cash flow hedges. Interest Rate Swap Derivative Instruments Pursuant to an International Swap Dealers Association, Inc. (“ISDA”) Master Agreement which was effective March 20, 2019, the Company on March 27, 2019, entered into an interest rate swap transaction utilizing a notional amount of $80.0 million, with an effective date of April 11, 2019 and a maturity date of October 11, 2023 (the “Rate Swap”). In December 2019, the Company amended the notional amount to $65.0 million. The Rate Swap was intended to manage the Company’s interest rate risk on its floating-rate indebtedness under the Company’s revolving credit facility. Under the terms of the Rate Swap, the Company received 1-month LIBOR, subj ect to a 0% fl oor, and made payments based on a fixed rate of 2.1975%. The Company had designated the Rate Swap derivative instrument as a cash flow hedge; however, during the three months ended September 30, 2020, the Company de-designated the Rate Swap derivative instrument. As a result, the balance in accumulated other comprehensive income, or “AOCI” was frozen at the time of de-designation. The Company recognized $0.3 million and $0.6 million, out of AOCI and into interest expense for the three and six months ended December 31, 2022. The remaining balance of $0.8 million frozen in AOCI will be amortized over the life of the Rate Swap through October 11, 2023. In connection with the revolver credit facility agreement entered into by the Company in April 2021 (see Note 11 Under the terms of the Amended Rate Swap, the Company receives 1-month LIBOR, subject to a 0% floor, and makes payments based on a fixed rate of 2.4725%, an increase of 0.275% from its original Rate Swap fixed rate of 2.1975%. The Amended Rate Swap utilizes the same notional amount of $65.0 million and maturity date of October 11, 2023 as the original interest rate swap. The Company did not designate the Amended Rate Swap as a cash flow hedge. The Company’s obligations under the Amended Rate Swap are secured by the collateral which secures the loans under the new Revolver Credit Facility (see Note 11 for details) on a pari passu and pro rata basis with the principal of such loans. Effect of Derivative Instruments on the Financial Statements Balance Sheets Fair values of derivative instruments on the Company’s consolidated balance sheets: Derivative Instruments Derivative Instruments Not Designated as Accounting Hedges (In thousands) December 31, 2022 June 30, 2022 December 31, 2022 June 30, 2022 Financial Statement Location: Short-term derivative assets: Coffee-related derivative instruments (1) $ 271 $ 2,144 $ 295 $ 555 Interest rate swap derivative instruments (1) — — 1,270 323 Long-term derivative assets: Coffee-related derivative instruments (2) — 37 — 140 Interest rate swap derivative instruments (2) — — — 166 Short-term derivative liabilities: Coffee-related derivative instruments (3) 885 3 4,467 2,346 ________________ (1) Included in “Short-term derivative assets” on the Company's consolidated balance sheets. (2) Included in “Long-term derivative assets” on the Company's consolidated balance sheets. (3) Included in “Short-term derivative liabilities” on the Company's consolidated balance sheets. Statements of Operations The following table presents pretax net gains and losses for the Company's derivative instruments designated as cash flow hedges, as recognized in “AOCI,” “Cost of goods sold” and “Interest expense”. Three Months Ended December 31, Six Months Ended December 31, Financial Statement Classification (In thousands) 2022 2021 2022 2021 Net (gains) losses recognized from AOCI to earnings - Interest rate swap (6) (4) 386 (4) Interest Expense Net losses reclassified from AOCI to earnings for de-designated Interest rate swap (273) (304) (952) (618) Interest Expense Net (losses) gains recognized in AOCI - Coffee-related (2,284) 5,132 (2,812) 10,991 AOCI Net gains recognized in earnings - Coffee - related 600 3,712 1,881 5,632 Cost of goods sold For the three and six months ended December 31, 2022 and 2021, there were no ga ins or losses recognized in earnings as a result of excluding amounts from the assessment of hedge effectiveness. Net (gains) losses on derivative instruments in the Company’s consolidated statements of cash flows also include net (gains) losses on coffee-related derivative instruments designated as cash flow hedges reclassified to cost of goods sold from AOCI in the three and six months ended December 31, 2022 and 2021. Gains and losses on coffee-related derivative instruments not designated as accounting hedges are included in “Other, net” in the Company’s consolidated statements of operations and in Net (gains) losses on derivative instruments in the Company’s consolidated statements of cash flows. Net gains and losses recorded in “Other, net” are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Net (losses) gains on coffee-related derivative instruments (1) $ (4,167) $ 872 $ (3,605) $ 2,422 Non-operating pension and other postretirement benefits 727 895 1,455 1,789 Other gains, net 170 — 488 — Other, net $ (3,270) $ 1,767 $ (1,662) $ 4,211 ___________ (1) Excludes net gains and losses on coffee-related derivative instruments designated as cash flow hedges recorded in cost of goods sold in the three and six months ended December 31, 2022 and 2021. Statement of Comprehensive Income (Loss) The following table provides the balances and changes in accumulated other comprehensive income (loss) related to derivative instruments for the indicated periods: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Accumulated other comprehensive income beginning balance $ (170) $ (8,429) $ (1,692) $ (4,176) Net (gains) losses recognized from AOCI to earnings - Interest rate swap (6) (4) 386 (4) Net losses reclassified from AOCI to earnings for partial unwind of interest swap - Interest rate swap (273) (304) (952) (618) Net losses (gains) recognized in AOCI - Coffee-related 2,284 (5,132) 2,812 (10,991) Net gains recognized in earnings - Coffee-related 600 3,712 1,881 5,632 Accumulated other comprehensive income ending balance $ 2,435 $ (10,157) $ 2,435 $ (10,157) Offsetting of Derivative Assets and Liabilities The Company has agreements in place that allow for the financial right of offset for derivative assets and liabilities at settlement or in the event of default under the agreements. Additionally, under certain coffee derivative agreements, the Company maintains accounts with its counterparties to facilitate financial derivative transactions in support of its risk management activities. The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2022 Derivative Assets $ 1,836 $ (566) $ — $ 1,270 Derivative Liabilities 5,352 (566) — 4,786 June 30, 2022 Derivative Assets 3,365 (2,349) — 1,016 Derivative Liabilities 2,349 (2,349) — — Cash Flow Hedges Changes in the fair value of the Company’s coffee-related derivative instruments designated as cash flow hedges are deferred in AOCI and subsequently reclassified into cost of goods sold in the same period or periods in which the hedged forecasted purchases affect earnings, or when it is probable that the hedged forecasted transaction will not occur by the end of the originally specified time period. Based on recorded values at December 31, 2022, $1.5 million of net losses on coffee-related derivative instruments designated as a cash flow hedge are expected to be reclassified into cost of goods sold within the next twelve months. These recorded values are based on market prices of the commodities as of December 31, 2022. The Company had designated the Rate Swap derivative instrument as a cash flow hedge; however, during the three months ended September 30, 2020, the Company de-designated the Rate Swap derivative instrument. The frozen AOCI is subsequently reclassified into interest expense in the period or periods when the hedged transaction affects earnings or when it is probable that the hedged forecasted transaction will not occur by the end of the originally specified time period. As of December 31, 2022, $0.8 million of net losses on the Rate Swap de-designated as a cash flow hedge are expected to be reclassified into interest expense within the next twelve months. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 5. Fair Value Measurements Assets and liabilities measured and recorded at fair value on a recurring basis were as follows: (In thousands) Total Level 1 Level 2 Level 3 December 31, 2022 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 271 $ — $ 271 $ — Coffee-related derivative liabilities (1) 885 — 885 — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) 295 — 295 — Coffee-related derivative liabilities (1) 4,467 — 4,467 — Interest rate swap derivative asset (2) 1,270 — 1,270 — Total Level 1 Level 2 Level 3 June 30, 2022 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 2,181 $ — $ 2,181 $ — Coffee-related derivative liabilities (1) 3 — 3 — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) 695 — 695 — Coffee-related derivative liabilities (1) 2,346 — 2,346 — Interest rate swap derivative asset (2) 489 — 489 — ____________________ (1) The Company's coffee-related derivative instruments are traded over-the-counter and, therefore, classified as Level 2. (2) The Company's interest rate swap derivative instrument are model-derived valuations with directly or indirectly observable significant inputs such as interest rate and, therefore, classified as Level 2. |
Accounts Receivable, Net
Accounts Receivable, Net | 6 Months Ended |
Dec. 31, 2022 | |
Receivables [Abstract] | |
Accounts Receivable, Net | Note 6. Accounts Receivable, Net (In thousands) December 31, 2022 June 30, 2022 Trade receivables $ 49,132 $ 44,219 Other receivables (1) 1,371 2,911 Allowance for credit losses (190) (195) Accounts receivable, net $ 50,313 $ 46,935 __________ (1) Includes vendor rebates and other non-trade receivables. |
Inventories
Inventories | 6 Months Ended |
Dec. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Inventories | Note 7. Inventories (In thousands) December 31, 2022 June 30, 2022 Coffee Processed $ 21,934 $ 32,486 Unprocessed 34,273 39,326 Total $ 56,207 $ 71,812 Tea and culinary products Processed 22,969 24,034 Unprocessed 58 58 Total $ 23,027 $ 24,092 Coffee brewing equipment parts 4,303 3,714 Total inventories $ 83,537 $ 99,618 |
Property, Plant and Equipment
Property, Plant and Equipment | 6 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Note 8. Property, Plant and Equipment (In thousands) December 31, 2022 June 30, 2022 Buildings and facilities $ 93,038 $ 92,948 Machinery, vehicles and equipment 218,841 219,095 Capitalized software 12,170 25,467 Office furniture and equipment 12,049 14,347 $ 336,098 $ 351,857 Accumulated depreciation (213,425) (224,760) Land 11,053 11,053 Property, plant and equipment, net $ 133,726 $ 138,150 Coffee Brewing Equipment (“CBE”) and Service Capitalized CBE included in machinery and equipment above are: (In thousands) December 31, 2022 June 30, 2022 Coffee Brewing Equipment $ 93,934 $ 93,549 Accumulated depreciation (68,520) (68,938) Coffee Brewing Equipment, net $ 25,414 $ 24,611 Depreciation expense related to capitalized CBE and other CBE related expenses provided to customers and reported in cost of goods sold were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Depreciation expense in COGS $ 1,810 $ 1,905 $ 3,618 $ 3,869 CBE Costs excl. depreciation exp 7,215 5,702 14,419 11,750 |
Intangible Assets
Intangible Assets | 6 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Note 9. Intangible Assets The following is a summary of the Company’s amortized and unamortized intangible assets: December 31, 2022 June 30, 2022 (In thousands) Weighted Average Amortization Period as of December 31, 2022 Gross Carrying Accumulated Net Gross Carrying Accumulated Net Amortized intangible assets: Customer relationships 4.2 $ 33,003 $ (22,992) $ 10,011 $ 33,003 $ (21,893) $ 11,110 Recipes 0.8 930 (819) 111 930 (752) 178 Trade name/brand name 0.9 510 (476) 34 510 (457) 53 Total amortized intangible assets $ 34,443 $ (24,287) $ 10,156 $ 34,443 $ (23,102) $ 11,341 Unamortized intangible assets: Trademarks, trade names and brand name with indefinite lives $ 4,522 $ — $ 4,522 $ 4,522 $ — $ 4,522 Total unamortized intangible assets $ 4,522 $ — $ 4,522 $ 4,522 $ — $ 4,522 Total intangible assets $ 38,965 $ (24,287) $ 14,678 $ 38,965 $ (23,102) $ 15,863 Aggregate amortization expense for the three months ended December 31, 2022 and 2021 was $0.6 million in each period. Aggregate amortization expense for the six months ended December 31, 2022 and 2021 was $1.2 million in each period. |
Employee Benefit Plans
Employee Benefit Plans | 6 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Note 10. Employee Benefit Plans Single Employer Pension Plans As of December 31, 2022, the Company has two defined benefit pension plans for certain employees, the "Farmer Bros. Plan" and the “Hourly Employees' Plan”. The Company froze benefit accruals and participation in these plans effective June 30, 2011 and October 1, 2016, respectively. After the plan freezes, participants do not accrue any benefits under the plan, and new hires are not eligible to participate in the plan. The net periodic benefit (credit) cost for the defined benefit pension plans is as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Interest cost $ 1,156 $ 848 $ 2,312 $ 1,696 Expected return on plan assets (1,009) (1,237) (2,018) (2,474) Amortization of net loss (1) 281 339 563 678 Net periodic benefit (credit) cost $ 428 $ (50) $ 857 $ (100) ___________ (1) These amounts represent the estimated portion of the net loss in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year. Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost December 31, 2022 June 30, 2022 Discount rate 4.50% 2.60% Expected long-term return on plan assets 6.50% 6.25% Multiemployer Pension Plans The Company participates in one multiemployer defined benefit pension plan that is union sponsored and collectively bargained for the benefit of certain employees subject to collective bargaining agreements, called the Western Conference of Teamsters Pension Plan ("WCTPP"). The Company makes contributions to this plan generally based on the number of hours worked by the participants in accordance with the provisions of negotiated labor contracts. The company also contributes to two defined contribution pension plans (All Other Plans) that are union sponsored and collectively bargained for the benefit of certain employees subject to collective bargaining agreements. Contributions made by the Company to the multiemployer pension plans were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Contributions to WCTPP $ 378 $ 226 $ 665 $ 471 Contributions to All Other Plans 8 10 16 17 Multiemployer Plans Other Than Pension Plans The Company participates in nine multiemployer defined contribution plans other than pension plans that provide medical, vision, dental and disability benefits for active, union-represented employees subject to collective bargaining agreements. The plans are subject to the provisions of the Employee Retirement Income Security Act of 1974, and provide that participating employers make monthly contributions to the plans in an amount as specified in the collective bargaining agreements. Also, the plans provide that participants make self-payments to the plans, the amounts of which are negotiated through the collective bargaining process. The Company’s participation in these plans is governed by collective bargaining agreements which expire on or before January 31, 2025. 401(k) Plan Farmer Bros. Co. 401(k) Plan (the “401(k) Plan”) is available to all eligible employees. The 401(k) Plan match portion is available to all eligible employees who have worked more than 1,000 hours during a calendar year and were employed at the end of the calendar year. Participants in the 401(k) Plan may choose to contribute a percentage of their annual pay subject to the maximum contribution allowed by the Internal Revenue Service. The Company's matching contribution is discretionary, based on approval by the Company's Board of Directors. Beginning in July 2021, the Company re-instated a 401(k) Plan matching program (the “401(k) Match”) for non-union employees, by matching 50% of any non-union employee's annual contribution to the 401(k) Plan, up to 6% of such employee's eligible income, which is substantially similar to the program prior to its suspension in March 2020. Beginning in January 2022, the Company amended the 401(k) Match, whereby the Company on a quarterly basis, will contribute, instead of cash, shares of the Company’s common stock, par value $1.00 per share (the “Common Stock”) with a value equal to 50% of any non-union employee's annual contribution to the 401(k) Plan, up to 6% of such employee's eligible income. The terms of the match are substantially the same as the safe-harbor non-elective contribution. The Company recorded matching contributions of $0.6 million and $1.1 million in operating expenses in the three and six months ended December 31, 2022, respectively and $0.5 million and $1.1 million in operating expenses in the three and six months ended December 31, 2021, respectively. Additionally, the Company makes an annual safe harbor non-elective contribution of Common Stock equal to 4% of each eligible participant’s annual plan compensation. During the three months ended December 31, 2022 and 2021, the Company contributed a total of 264,712 and 82,437 of shares Common Stock with a value of $0.6 million and $0.7 million, respectively, to eligible participants’ annual plan compensation. During the six months ended December 31, 2022 and 2021, the Company contributed a total of 521,764 and 134,034 of shares Common Stock with a value of $1.2 million and $1.3 million, respectively, to eligible participants’ annual plan compensation. Effective January 1, 2023, the Company eliminated the 4% non-elective contribution and changed the Company match to 100% of the first 3% each eligible employee contributes plus 50% on the next 2% they contribute. Effective January 1, 2022, the Company amended the 401(k) Plan to, among other things, increase the number of shares of Common Stock available for issuance under the 401(k) Plan by 2,000,000 additional shares of Common Stock and permit participants in the 401(k) Plan to invest a portion of their 401(k) Plan accounts into Common Stock. Effective January 1, 2022, the Company merged the Company’s Employee Stock Ownership Plan (“ESOP”) into the 401(k) Plan and transferred all of the assets and shares in the ESOP to the 401(k) Plan. Postretirement Benefits Retiree Medical Plan and Death Benefit On March 23, 2020, the Company announced a plan to amend and terminate the postretirement medical benefit plan that covers qualified non-union retirees and certain qualified union retirees (“Retiree Medical Plan”) effective January 1, 2021. As a result, the re-measurement generated a prior service credit. This credit, along with actuarial gains, were amortized over the remaining months of the plan through January 1, 2021. The Retiree Medical Plan is now terminated. The Company provides a postretirement death benefit (the “Death Benefit” Plan) to certain employees and retirees, subject, in the case of current employees, to continued employment with the Company until retirement and certain other conditions related to the manner of employment termination and manner of death. In June 2021, the Company amended the Death Benefit Plan effective immediately, which triggered re-measurement of the plan. In conjunction with the amendment, the Company created a new Executive Death Benefit Plan (the “Executive Death Benefit Plan”) for a small group of participants in the Death Benefit Plan. Under the Executive Death Benefit Plan, the participants receive the same benefits they would have received under the Death Benefit Plan. The following table shows the components of net periodic postretirement benefit cost for the Retiree Medical Plan and Death Benefit Plan for the three and six months ended December 31, 2022 and 2021. Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Components of Net Periodic Postretirement Benefit Cost: Service cost $ — $ — $ — $ — Interest cost 10 7 19 13 Amortization of net gain — 3 — 6 Net periodic postretirement benefit cost $ 10 $ 10 $ 19 $ 19 Weighted-Average Assumptions Used to Determine Net Periodic Postretirement Benefit Cost Fiscal year 2023 2022 Retiree Medical Plan discount rate N/A N/A Death Benefit Plan discount rate 4.77% 2.72% |
Debt Obligations
Debt Obligations | 6 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt Obligations | Note 11. Debt Obligations The following table summarizes the Company’s debt obligations: December 31, 2022 June 30, 2022 (In thousands) Debt Origination Date Maturity Principal Borrowing Amount Carrying Value Weighted Average Interest Rate (1) Carrying Value Weighted Average Interest Rate Revolver Various 4/26/2027 N/A $ 67,000 5.05 % $ 63,000 2.75 % Term Loan 8/31/2022 4/26/2027 $47,000 46,217 45,600 113,217 108,600 Unamortized deferred debt financing costs (953) (1,677) Total $ 112,264 $ 106,923 __________ (1) The weighted average interest rate excludes the fixed rate on the de-designated Amended Rate Swap Revolver Facility On April 26, 2021, the Company entered into a senior secured facility which included a Revolver Credit Facility Agreement (the "Revolver Credit Facility"). The Revolver Credit Facility had a commitment of up to $80.0 million and a maturity date of April 25, 2025. On August 8, 2022, the Company and certain of its subsidiaries entered into the Increase Joinder and Amendment No. 2 to Credit Agreement (the “2nd Amendment”), with Wells Fargo, as administrative agent for each member of the lender group and as a lender. The 2nd Amendment amends certain terms and conditions of the Revolver Credit Facility by, among other things: (i) increasing the maximum revolver amount by $10.0 million to an aggregate maximum revolver commitment amount of $90.0 million; and (ii) replacing the London Interbank Offered Rate (LIBOR) interest rate benchmark (which had an applicable margin of 2.25% for LIBOR rate loans) with the secured overnight financing rate (SOFR) interest rate benchmark (which has an applicable margin of 1.75% for SOFR rate loans). Availability under the Revolver Credit Facility is calculated as the lesser of (a) $90.0 million or (b) the amount equal to the sum of (i) 85% of eligible accounts receivable (less a dilution reserve), plus (ii) the lesser of: (a) 80% of eligible raw material inventory, eligible in-transit inventory and eligible finished goods inventory (collectively, “Eligible Inventory”), and (b) 85% of the net orderly liquidation value of eligible inventory, minus (c) applicable reserve. The Revolver Credit Facility contains customary affirmative and negative covenants and restrictions typical for a financing of this type. Non-compliance with one or more of the covenants and restrictions could result in the full or partial principal balance of the Revolver Credit Facility becoming immediately due and payable and termination of the commitments. Prior Term Loan Facility On April 26, 2021, the Company borrowed $47.5 million of term loans from various financial institutions as part of a Credit Agreement, dated as of April 26, 2021 (the “Prior Term Loan Facility”). The following is a summary description of the Prior Term Loan Facility: 1. total commitment of $47.5 million in the form of a term loan; 2. maturity date of April 25, 2025 and scheduled payback required on the principal prior to the maturity date; 3. fully collateralized by all existing and future capital stock of the borrowers (other than the Company) and all of the borrowers' personal and real property; 4. interest under the Term Loan is either LIBOR + 6.5% per annum, or (b) base rate + 5.50% per annum, with a 3% floor on base rate; and 5. commencing on the fiscal quarter ending on March 31, 2022, quarterly minimum EBITDA and fixed charge coverage ratio requirements specified therein. Principal payments on the Prior Term Loan Facility were due quarterly in the amount of $0.95 million. New Term Loan Facility On August 31, 2022, the Company entered into Amendment No. 3 to Credit Agreement (the “3rd Amendment”), with the lenders party thereto, and Wells Fargo Bank, as administrative agent for each member of the lender group and as a lender. The 3rd Amendment amends certain terms and conditions of the Revolver Credit Facility by, among other things: (i) adding a new $47.0 million term loan (the “Term Loan”); (ii) extending the maturity date of the Company’s obligations under the Revolver Credit Facility from April 25, 2025 to April 26, 2027; provided, that if the maturity date of the Revolver Commitments is extended on or prior to April 1, 2027 to a date that is after April 26, 2027, then the maturity of the Term Loan Facility shall be August 31, 2037; (iii) releasing liens securing the obligations under the Revolver Facility Credit on various real properties owned by the Company; (iv) commencing on or around June 30, 2023, obligating the Company to maintain a Fixed Charge Coverage Ratio, calculated for each 12-month period ending on the last day of each fiscal month, of at least 1:00 to 1:00; and (v) lowering the Letter of Credit Fee payable with respect to letters of credit issued under the Credit Agreement from 2.25% to 1.75% of the average amount of the Letter of Credit Usage during the immediately preceding month. The proceeds of the Term Loan Facility were used to repay the outstanding term loans under the Term Credit Facility Agreement. With the repayment of the Company’s outstanding loans and other obligations under the Term Credit Facility Agreement, the Company is no longer subject to the minimum EBITDA covenants contained therein. As part of the refinancing transaction, the Company expensed $1.5 million in unamortized deferred financing costs, discount and payoff premium for the six months ended December 31, 2022, which are included in interest expense on the consolidated statement of operations. Covenant Compliance The Term Loan Facility contains customary affirmative and negative covenants and restrictions typical for a financing of this type that, among other things, require the Company to satisfy certain financial covenants and restrict the Company's and its subsidiaries' ability to incur additional debt, pay dividends and make distributions, make certain investments and acquisitions, repurchase its stock and prepay certain indebtedness, create liens, enter into agreements with affiliates, modify the nature of its business, transfer and sell material assets and merge or consolidate. As of December 31, 2022, the Company was in compliance with all of the financial covenants under the Revolver Credit Facility and the Term Loan Facility (collectively, the “Credit Facilities”). Non-compliance with one or more of the covenants and restrictions could result in the full or partial principal balance of the Term Loan Facility Agreement and the Revolver Credit Facility becoming immediately due and payable and termination of the commitments which could impact our liquidity. Accordingly, an event of default could have a material and adverse impact on us. If we are unable to cure, obtain a waiver from the lenders, or refinance the Credit Facilities, we anticipate not being able to meet the current contractual covenant beginning June 30, 2023. We consider it probable that management’s plans, including the options described above, will be able to alleviate the potential noncompliance with the debt covenant prior to June 30, 2023. Interest Rate Swap In connection with the Revolver Credit Facility and Prior Term Loan Facility , the Company executed the Amended Rate Swap. Under the terms of the Amended Rate Swap, the Company receives 1-month LIBOR, subject to a 0% floor, and makes payments based on a fixed rate of 2.4725%, an increase of 0.275% from its original interest rate swap fixed rate of 2.1975%. The Amended Rate Swap utilizes the same notional amount of $65.0 million and maturity date of October 11, 2023 as the original interest rate swap. Beginning with the quarter ended December 31, 2022, the Company is required to make monthly principal payments on the Term Loan debt obligation in the amount of $261 thousand. At December 31, 2022 , the Company had outstanding borrowings on the Revolver Credit Facility of $67.0 million and had utilized $4.1 million of the letters of credit sublimit. At December 31, 2022, we had $14.3 million available on our Revolver Credit Facility. |
Share-Based Compensation
Share-Based Compensation | 6 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation | Note 12. Share-based Compensation Farmer Bros. Co. Amended and Restated 2017 Long-Term Incentive Plan (the “2017 Plan”) As of December 31, 2022, there were 1,455,761 shares available under the 2017 Plan including shares that were forfeited under the prior plans for future issuance. On December 15, 2021, the Company’s stockholders approved an amendment (the “Plan Amendment”) to the 2017 Plan, which (i) increased the number of shares of Common Stock available for grant under the Plan by 1,500,000 additional shares of Common Stock and (ii) allows the Company to utilize awards to attract and incentivize non-employee consultants. Farmer Bros. Co. 2020 Inducement Incentive Award Plan (the “2020 Inducement Plan”) As of December 31, 2022, there were 60,475 shares available under the 2020 Inducement Plan. Non-qualified stock options with time-based vesting (“NQOs”) One-third of the total number of shares subject to each stock option vest ratably on each of the first three anniversaries of the grant date, contingent on continued employment, and subject to accelerated vesting in certain circumstances. There were no NQOs granted during the six months ended December 31, 2022. The following table summarizes NQO activity for six months ended December 31, 2022: Outstanding NQOs: Number Weighted Weighted Aggregate Outstanding at June 30, 2022 450,687 12.39 4.34 $ — Granted — — — — Exercised — — — — Cancelled/Forfeited (11,807) 15.94 — — Expired (27,973) 19.77 — — Outstanding at December 31, 2022 410,907 11.79 3.83 $ — Exercisable at December 31, 2022 366,929 12.30 3.78 $ — The aggregate intrinsic values outstanding at the end of period in the table above represent the total pretax intrinsic values, based on the closing price of Common Stock of $4.61 and $4.69 at December 31, 2022 and June 30, 2022, respectively, representing the last trading day of the respective periods, which would have been received by NQO holders had all award holders exercised their NQOs that were in-the-money as of those dates. NQOs outstanding that are expected to vest are net of estimated forfeitures. There we re no opti ons exercised during six months ended December 31, 2022 and 2021. At December 31, 2022 and June 30, 2022, respectively, there was $32.7 thousand and $0.2 million of unrecognized NQO compensation cost. The unrecognized NQO compensation cost at December 31, 2022 is expected to be recognized over the weighted average period of four months. Total compensation expense for NQOs was $23.5 thousand and $0.2 million for the three months ended December 31, 2022 and 2021, respectively. Total compensation expense for NQOs was $0.1 million and $0.3 million for the six months ended December 31, 2022 and 2021, respectively. Non-qualified stock options with performance-based and time-based vesting ( “ PNQs”) The following table summarizes PNQ activity for the six months ended December 31, 2022: Outstanding PNQs: Number Weighted Weighted Aggregate Outstanding at June 30, 2022 2,212 30.91 0.83 $ — Granted — — — — Exercised — — — — Cancelled/Forfeited — — — — Expired (1,221) 29.48 — — Outstanding at December 31, 2022 991 32.84 0.86 $ — Exercisable at December 31, 2022 991 32.84 0.86 $ — The aggregate intrinsic values outstanding at the end of each fiscal period in the table above represent the total pretax intrinsic values, based on the Company’s closing stock price of $4.61 and $4.69 at December 31, 2022 and June 30, 2022, respectively, representing the last trading day of the respective fiscal periods, which would have been received by PNQ holders had all award holders exercised their PNQs that were in-the-money as of those dates. There were no options exercised during six months ended December 31, 2022 and 2021. At December 31, 2022 and June 30, 2022, there was no unrecognized PNQ compensation cost. There was no compensation expense related to PNQs in the three and six months ended December 31, 2022 and 2021. Restricted Stock The following table summarizes restricted stock activity for the six months ended December 31, 2022: Outstanding and Nonvested Restricted Stock Awards: Shares Weighted Average Outstanding and nonvested at June 30, 2022 816,811 6.67 Granted 486,196 6.15 Vested/Released (312,925) 6.64 Cancelled/Forfeited (80,395) 6.15 Outstanding and nonvested at December 31, 2022 909,687 6.56 The weighted average grant date fair value of RSUs granted during the quarters ended December 31, 2022 and 2021 were $6.15 and $8.22 , respectively. The total grant-date fair value of restricted stock granted during the six months ended December 31, 2022 was $3.2 million . The total fair value of awards vested during the six months ended December 31, 2022 and 2021 were $1.6 million and $2.2 million , respectively. At December 31, 2022 and June 30, 2022, there was $5.0 million and $3.9 million, respectively, of unrecognized compensation cost related to restricted stock. The unrecognized compensation cost related to restricted stock at December 31, 2022 is expected to be recognized over the weighted average period of 2.2 years . Total compensation expense for restricted stock was $0.7 million and $0.6 million, respectively, in the three months ended December 31, 2022 and 2021. Total compensation expense for restricted stock was $1.4 million and $1.0 million, respectively, in the six months ended December 31, 2022 and 2021. Performance-Based Restricted Stock Units (“PBRSUs”) The following table summarizes PBRSU activity for the six months ended December 31, 2022: Outstanding and Nonvested PBRSUs: PBRSUs Weighted Average Outstanding and nonvested at June 30, 2022 456,993 6.16 Granted (1) 214,842 6.40 Vested/Released — — Cancelled/Forfeited (19,540) 15.35 Outstanding and nonvested at December 31, 2022 652,295 5.96 _____________ (1) The target number of PBRSUs is presented in the table. Under the terms of the awards, the recipient may earn between 0% and 200% of the target number of PBRSUs depending on the extent to which the Company meets or exceeds the achievement of the applicable financial performance goals. The weighted average grant date fair value of PBRSUs granted during the quarters ended December 31, 2022 and 2021 were $6.40 and $8.91, respectively. The total grant-date fair value of PBRSUs granted during the six months ended December 31, 2022 was $1.4 million . The total fair value of awards vested during the six months ended December 31, 2021 were $3.2 thousand . At December 31, 2022 and June 30, 2022, there was $2.6 million and $1.7 million, respectively, of unrecognized PBRSU compensation cost. The unrecognized PBRSU compensation cost at December 31, 2022 is expected to be recognized over the weighted average period of 2.1 years. Total compensation expense for PBRSUs was $0.2 million and $183.6 thousand, respectively, for the three months ended December 31, 2022 and 2021. Total compensation expense for PBRSUs was $0.4 million and $0.3 million, respectively, for the six months ended December 31, 2022 and 2021. Cash-Settled Restricted Stock Units (“CSRSUs”) CSRSUs vest in equal installments over a three-year period from the grant date, and are cash-settled upon vesting based on the closing share price of Common Stock on the vesting date. The CSRSUs are accounted for as liability awards, and compensation expense is measured at fair value on the date of grant and recognized on a straight-line basis over the vesting period net of forfeitures. Compensation expense is remeasured at each reporting date with a cumulative adjustment to compensation cost during the period based on changes in the closing share price of Common Stock. The following table summarizes CSRSU activity for the six months ended December 31, 2022: Outstanding and Nonvested CSRSUs: CSRSUs Weighted Average Outstanding and nonvested at June 30, 2022 145,645 6.36 Granted 178,099 6.40 Vested/Released (42,670) 6.24 Cancelled/Forfeited (55,351) 6.10 Outstanding and nonvested at December 31, 2022 225,723 6.47 The weighted average grant date fair value of CSRSUs granted during the quarters ended December 31, 2022 and 2021 were $6.40 and $8.91, respectively. The total grant-date fair value of CSRSUs granted during the six months ended December 31, 2022 was $1.1 million . The total fair value of awards vested during the six months ended December 31, 2022 and 2021 was $0.2 million and $0.4 million, respectively. At December 31, 2022 and June 30, 2022, there was $1.0 million and $0.6 million, respectively, of unrecognized compensation cost related to CSRSU. The unrecognized compensation cost related to CSRSU at December 31, 2022 is expected to be recognized over the weighted average period of 2.5 years . Total compensation expense for CSRSUs was $0.1 million and $0.1 million, respectively for the three months ended December 31, 2022 and 2021. Total compensation expense for CSRSUs was $0.1 million and |
Other Current Liabilities
Other Current Liabilities | 6 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Other Current Liabilities | Note 13. Other Current Liabilities Other current liabilities consist of the following: (In thousands) December 31, 2022 June 30, 2022 Accrued workers’ compensation liabilities $ 851 $ 947 Finance lease liabilities 193 193 Other (1) 4,582 4,955 Other current liabilities $ 5,626 $ 6,095 _________ (1) Includes accrued property taxes, sales and use taxes and insurance liabilities. |
Other Long-Term Liabilities
Other Long-Term Liabilities | 6 Months Ended |
Dec. 31, 2022 | |
Other Liabilities Disclosure [Abstract] | |
Other Long-Term Liabilities | Note 14. Other Long-Term Liabilities Other long-term liabilities include the following: (In thousands) December 31, 2022 June 30, 2022 Deferred compensation (1) $ 255 $ 195 Finance lease liabilities 347 409 Deferred income taxes and other liabilities 735 735 Other long-term liabilities $ 1,337 $ 1,339 ___________ (1) Includes payroll taxes and cash-settled restricted stock units liabilities. |
Income Taxes
Income Taxes | 6 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 15. Income Taxes The income tax expense and the related effective tax rates are as follows (in thousands, except effective tax rate): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Income tax expense $ 40 $ 126 $ 83 $ 188 Effective tax rate (0.3) % (2.4) % (0.4) % (2.5) % The Company’s interim tax provision is determined using an estimated annual effective tax rate and adjusted for discrete taxable events that may occur during the quarter. The Company recognizes the effects of tax legislation in the period in which the law is enacted. Deferred tax assets and liabilities are remeasured using enacted tax rates expected to apply to taxable income in the years the Company estimates the related temporary differences to reverse. The Company evaluates its deferred tax assets quarterly to determine if a valuation allowance is required. In making such assessment, significant weight is given to evidence that can be objectively verified, such as recent operating results, and less consideration is given to less objective indicators such as future income projections. Tax expense in the three months ended December 31, 2022 was $40 thousand compared to $0.1 million in the three months ended December 31, 2021, which primarily relates to state income tax expense in certain jurisdictions. Tax expense in the six months ended December 31, 2022 was $83 thousand compared to $0.2 million in the six months ended December 31, 2021, which primarily relates to state income tax expense in certain jurisdictions. The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by U.S. federal, state and local tax authorities. With limited exceptions, as of December 31, 2022, the Company is no longer subject to income tax audits by taxing authorities for any years prior to 2019. Although the outcome of tax audits is always uncertain, the Company does not believe the outcome of any future audit will have a material adverse effect on the Company’s consolidated financial statements. |
Net Loss Per Common Share
Net Loss Per Common Share | 6 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Common Share | Note 16. Net Loss Per Common Share Basic net loss per common share is calculated by dividing net loss attributable to the Company by the weighted average number of common shares outstanding during the periods presented. Diluted net loss per common share is calculated by dividing diluted net loss attributable to the Company by the weighted average number of common shares outstanding adjusted to include the effect, if dilutive, of the exercise of in-the-money stock options, unvested performance-based restricted stock units, and shares of the Company’s Series A Convertible Participating Cumulative Perpetual Preferred Stock, par value $1.00 per share (“Series A Preferred Stock”), as converted, during the periods presented. The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such option’s exercise prices were greater than the average market price of our common shares for the period) and unvested performance-based restricted stock units because their inclusion would have been anti-dilutive. The following table presents the computation of basic and diluted net earnings loss per common share: Three Months Ended December 31, Six Months Ended December 31, (In thousands, except share and per share amounts) 2022 2021 2022 2021 Undistributed net loss available to common stockholders $ (13,608) $ (5,334) $ (20,982) $ (7,830) Undistributed net loss available to nonvested restricted stockholders and holders of convertible preferred stock — (234) — (309) Net loss available to common stockholders - basic $ (13,608) $ (5,568) $ (20,982) $ (8,139) Weighted average common shares outstanding - basic 18,723,957 18,106,151 19,243,707 18,034,658 Effect of dilutive securities: Shares issuable under stock options — — — — Weighted average common shares outstanding - diluted 18,723,957 18,106,151 19,243,707 18,034,658 Net loss available to common stockholders per common share—basic $ (0.73) $ (0.31) $ (1.09) $ (0.45) Net loss available to common stockholders per common share—diluted $ (0.73) $ (0.31) $ (1.09) $ (0.45) The following table summarizes weighted average anti-dilutive securities excluded from the computation of diluted net loss per common share for the periods indicated: Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Shares issuable under stock options 410,907 481,429 410,907 487,088 Shares issuable under convertible preferred stock — 444,849 — 444,849 Shares issuable under PBRSUs 501,141 498,210 469,297 437,211 |
Preferred Stock
Preferred Stock | 6 Months Ended |
Dec. 31, 2022 | |
Preferred Stock [Abstract] | |
Preferred Stock | Note 17. Preferred Stock The Company is authorized to issue 500,000 shares of preferred stock at a par value of $1.00, including 21,000 authorized shares of Series A Preferred Stock. There are no preferred shares issued and outstanding as of December 31, 2022. Effective August 25, 2022, 12,964 shares of Series A Preferred Stock were converted into 399,208 shares of common stock at a conversion price of $38.32, in accordance with the terms of the Company’s Designation of Series A Preferred Stock. The terms of the Series A Preferred Stock are disclosed in Note 20 to the Consolidated Financial Statements included in the 2022 Form 10-K. The shares of Series A Preferred Stock were originally issued to Boyd Coffee Company (now known as BCC Newco, Inc.) (“BCC”), on October 2, 2017, pursuant to that certain Asset Purchase Agreement, dated as of August 18, 2017 (the “Purchase Agreement”), by and among the Company, Boyd Assets Co., a Delaware corporation and wholly owned subsidiary of the Company, BCC and each of the parties set forth on Exhibit A thereto. 1,736 shares of Series A Preferred Stock originally issued to BCC in accordance with the terms of the Purchase Agreement were previously reacquired and cancelled by the Company as part of a settlement with BCC on July 26, 2022. The shares of Series A Preferred Stock converted represented all of the issued and outstanding shares of Series A Preferred Stock. The Company withheld 914 shares of Series A Preferred Stock pending satisfaction of certain indemnification claims (“Holdback Shares”) against the Seller. As a result of the settlement entered into with BCC, the Company recorded a $1.9 million gain on settlement with the sellers, in general and administrative expense on the consolidated statement of operations, which included the cancellation of preferred shares and settlement of acquisition related contingent liabilities, |
Revenue Recognition
Revenue Recognition | 6 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Note 18. Revenue Recognition The Company’s primary sources of revenue are sales of coffee, tea and culinary products. The Company recognizes revenue when control of the promised good or service is transferred to the customer and in amounts that the Company expects to collect. The timing of revenue recognition takes into consideration the various shipping terms applicable to the Company’s sales. The Company delivers products to customers through Direct-store-delivery (“DSD”) to the Company’s customers at their place of business and Direct ship from the Company’s warehouse to the customer’s warehouse, facility or address. Each delivery or shipment made to a third party customer is to satisfy a performance obligation. Performance obligations generally occur at a point in time and are satisfied when control of the goods passes to the customer. The Company is entitled to collection of the sales price under normal credit terms in the regions in which it operates. The Company disaggregates net sales from contracts with customers based on the characteristics of the products sold: Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 (In thousands) $ % of total $ % of total $ % of total $ % of total Net Sales by Product Category: Coffee (Roasted) $ 82,725 62.3 % $ 75,506 63.8 % $ 161,019 63.4 % $ 146,104 64.4 % Tea & Other Beverages (1) 26,686 20.2 % 22,891 19.3 % 47,632 18.7 % 41,928 18.5 % Culinary 16,372 12.3 % 13,913 11.7 % 31,269 12.3 % 26,988 11.9 % Spices 5,709 4.3 % 5,059 4.3 % 11,733 4.6 % 10,258 4.5 % Net sales by product category 131,492 99.1 % 117,369 99.1 % 251,653 99.0 % 225,278 99.3 % Delivery Surcharge 1,200 0.9 % 1,076 0.9 % 2,420 1.0 % 1,529 0.7 % Net sales $ 132,692 100.0 % $ 118,445 100.0 % $ 254,073 100.0 % $ 226,807 100.0 % ____________ (1) Includes all beverages other than roasted coffee, including frozen liquid coffee, and iced and hot tea, including cappuccino, cocoa, granitas, and concentrated and ready-to drink cold brew and iced coffee. The Company does not have any material contract assets and liabilities as of December 31, 2022. Receivables from contracts with customers are included in “Accounts receivable, net” on the Company’s consolidated balance sheets. At December 31, 2022 and June 30, 2022, “Accounts receivable, net” included, $49.1 million and $44.2 million, respectively, in receivables from contracts with customers. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 19. Commitments and Contingencies For a detailed discussion about the Company’s commitments and contingencies, see Note 18, “Commitments and Contingencies” in the Notes to Consolidated Financial Statements in the 2022 Form 10-K. During the six months ended December 31, 2022, other than the following, or as otherwise disclosed herein, there were no material changes in the Company’s commitments and contingencies. Purchase Commitments As of December 31, 2022, the Company had committed to purchase green coffee inventory totaling $76.2 million under fixed-price contracts, and $14.6 million in inventory and other purchases under non-cancelable purchase orders. Legal Proceedings Council for Education and Research on Toxics (“CERT”) v. Brad Berry Company Ltd., et al., Superior Court of the State of California, County of Los Angeles On August 31, 2012, CERT filed an amendment to a private enforcement action adding a number of companies as defendants, including the Company’s subsidiary, Coffee Bean International, Inc., which sell coffee in California under the State of California's Safe Drinking Water and Toxic Enforcement Act of 1986 (“Prop 65”). The suit alleges that the defendants have failed to issue clear and reasonable warnings in accordance with Prop 65 that the coffee they produce, distribute, and sell contains acrylamide. This lawsuit was filed in Los Angeles Superior Court (the “Court”). CERT alleges that the Company and the other defendants failed to provide warnings for their coffee products of exposure to the chemical acrylamide as required under Prop 65. Plaintiff seeks equitable relief and civil penalties in the amount of the statutory maximum of $2,500 per day per violation of Prop 65. The Plaintiff asserts that every consumed cup of coffee, absent a compliant warning, is equivalent to a violation under Prop 65. The Company, as part of a joint defense group (“JDG”) organized to defend against the lawsuit, disputes the claims of CERT. Acrylamide is not added to coffee but is present in all coffee in small amounts (parts per billion) as a byproduct of the coffee bean roasting process. A series of procedural and legislative developments occurred in the ensuing years, and at hearings in August 2020, the Court denied CERT’s motion for summary judgment and granted the JDG’s motion for summary judgment. Notice of Judgment in favor of defendants was entered on October 6, 2020. CERT has appealed. The Company believe that the likelihood that the Company will ultimately incur a loss in connection with this litigation is less than reasonably possible. The Company is a party to various other pending legal and administrative proceedings. It is management’s opinion that the outcome of such proceedings will not have a material impact on the Company’s financial position, results of operations, or cash flows. |
Sales of Assets
Sales of Assets | 6 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Sales of Assets | Note 20. Sales of Assets Sale of Branch Property During the six months ended December 31, 2022, the Company completed the sale of the following branch properties: (In thousands) Name of Branch Property Date Sold Sales Price Net Proceeds Gain on Sale Portland, Oregon 9/23/2022 $ 1,990 $ 1,880 $ 1,770 San Diego, California 9/19/2022 7,574 7,169 6,425 Fresno, California 10/7/2022 760 716 648 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Accounting | Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial data have been included. Operating results for the six months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2023. The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the Securities and Exchange Commission (the “SEC”) on September 2, 2022, and the Form 10-K/A filed on October 27, 2022 (the “2022 Form 10-K”). For a detailed discussion about the Company’s significant accounting policies, see Note 2, “ Summary of Significant Accounting Policies, ” in the Notes to Consolidated Financial Statements in the 2022 Form 10-K. During the six months ended December 31, 2022, there were no significant updates made to the Company’s significant accounting policies. Cash Equivalents At December 31, 2022, we had $17.6 million of unrestricted cash and cash equivalents and $2.3 million in restricted cash on deposit in broker accounts to satisfy margin requirements associated with certain coffee-related derivative instruments resulting from a decline in the “C” market price of green coffee during the three months ended December 31, 2022. Further changes in commodity prices and the number of coffee-related derivative instruments held could have a significant impact on cash deposit requirements under our broker and counterparty agreements and may adversely affect our liquidity. At June 30, 2022, none of the cash in the Company’s coffee-related derivative margin accounts was restricted. Further changes in commodity prices and the number of coffee-related derivative instruments held could have a significant impact on cash deposit requirements under certain of the Company's broker and counterparty agreements. |
Principles of Consolidation | Principles of ConsolidationThe consolidated financial statements include the accounts of the Company and its direct and indirect wholly owned subsidiaries FBC Finance Company, a California corporation, Coffee Bean Holding Co., Inc., a Delaware corporation and, the parent company of Coffee Bean International, Inc., an Oregon corporation, China Mist Brands, Inc., a Delaware corporation, and Boyd Assets Co., a Delaware corporation. All intercompany balances and transactions have been eliminated. |
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company reviews its estimates on an ongoing basis using currently available information. Changes in facts and circumstances may result in revised estimates and actual results may differ from those estimates. |
Concentration of Credit Risk | Concentration of Credit Risk At December 31, 2022 and June 30, 2022, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits), derivative instruments and trade receivables. The Company does not have any credit-risk related contingent features that would require it to post additional collateral in support of its net derivative asset positions. Approximately 36% and 35% of the Company’s accounts receivable balance was with five customers at December 31, 2022 and June 30, 2022, respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The accounts receivables are generally short-term and all estimated credit losses have been appropriately considered in establishing the allowance for credit losses. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (the “FASB”). ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its consolidated financial statements. The following table provides a brief description of the recent ASUs applicable to the Company: Standard Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2020, the FASB issued ASU No. 2020-04, “Facilitation of the Effect of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) The London Interbank Offered Rate (LIBOR) is being discontinued between December 2021 and June 2023. The Company has not entered into any new contracts after December 31, 2021. With the overnight, 1-month, 3-month, 6-month and 12-month USD LIBOR rates being published through June 30, 2023, we will continue to leverage these for the existing contracts. ASU 2020-04 provides temporary optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the transition from LIBOR to alternative reference rate. Issuance date of March 12, 2020 through December 31, 2024. The Company does not anticipate any material impacts on its consolidated financial statements. |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Lease, Cost | The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Operating lease expense $ 1,986 $ 1,888 $ 3,946 $ 3,670 Finance lease expense: Amortization of finance lease assets 41 41 82 82 Interest on finance lease liabilities 9 11 18 23 Total lease expense $ 2,036 $ 1,940 $ 4,046 $ 3,775 Other Information: Six Months Ended December 31, (In thousands) 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,882 $ 3,351 Operating cash flows from finance leases 18 73 Financing cash flows from finance leases 96 23 |
Lessee, Operating Lease, Liability, Maturity | December 31, 2022 (In thousands) Operating Leases Finance Leases 2023 $ 4,001 $ 96 2024 7,829 193 2025 6,650 193 2026 5,567 96 2027 4,127 — Thereafter 4,008 — Total lease payments 32,182 578 Less: interest (4,270) (54) Total lease obligations $ 27,912 $ 524 |
Assets And Liabilities, Lessee | Lease term and discount rate: December 31, 2022 June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 6.3 6.3 Finance lease 3.0 3.5 Weighted-average discount rate: Operating lease 6.00 % 5.69 % Finance lease 6.50 % 6.50 % |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended | 6 Months Ended |
Dec. 31, 2022 | Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Schedule of Notional Amounts of Outstanding Derivative Positions | The following table summarizes the notional volumes for the coffee-related derivative instruments held by the Company at December 31, 2022 and June 30, 2022: (In thousands) December 31, 2022 June 30, 2022 Derivative instruments designated as cash flow hedges: Long coffee pounds 3,638 4,200 Derivative instruments not designated as cash flow hedges: Long coffee pounds 8,377 516 Short coffee pounds (4,688) — Total 7,327 4,716 | |
Schedule of Fair Values of Derivative Instruments on the Consolidated Balance Sheets | Fair values of derivative instruments on the Company’s consolidated balance sheets: Derivative Instruments Derivative Instruments Not Designated as Accounting Hedges (In thousands) December 31, 2022 June 30, 2022 December 31, 2022 June 30, 2022 Financial Statement Location: Short-term derivative assets: Coffee-related derivative instruments (1) $ 271 $ 2,144 $ 295 $ 555 Interest rate swap derivative instruments (1) — — 1,270 323 Long-term derivative assets: Coffee-related derivative instruments (2) — 37 — 140 Interest rate swap derivative instruments (2) — — — 166 Short-term derivative liabilities: Coffee-related derivative instruments (3) 885 3 4,467 2,346 ________________ (1) Included in “Short-term derivative assets” on the Company's consolidated balance sheets. (2) Included in “Long-term derivative assets” on the Company's consolidated balance sheets. (3) Included in “Short-term derivative liabilities” on the Company's consolidated balance sheets. | |
Schedule of Pretax Effect of Derivative Instruments on Earnings and OCI | The following table presents pretax net gains and losses for the Company's derivative instruments designated as cash flow hedges, as recognized in “AOCI,” “Cost of goods sold” and “Interest expense”. Three Months Ended December 31, Six Months Ended December 31, Financial Statement Classification (In thousands) 2022 2021 2022 2021 Net (gains) losses recognized from AOCI to earnings - Interest rate swap (6) (4) 386 (4) Interest Expense Net losses reclassified from AOCI to earnings for de-designated Interest rate swap (273) (304) (952) (618) Interest Expense Net (losses) gains recognized in AOCI - Coffee-related (2,284) 5,132 (2,812) 10,991 AOCI Net gains recognized in earnings - Coffee - related 600 3,712 1,881 5,632 Cost of goods sold | |
Schedule of Net Realized and Unrealized Gains and Losses Recorded in 'Other, net' | Net gains and losses recorded in “Other, net” are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Net (losses) gains on coffee-related derivative instruments (1) $ (4,167) $ 872 $ (3,605) $ 2,422 Non-operating pension and other postretirement benefits 727 895 1,455 1,789 Other gains, net 170 — 488 — Other, net $ (3,270) $ 1,767 $ (1,662) $ 4,211 ___________ (1) Excludes net gains and losses on coffee-related derivative instruments designated as cash flow hedges recorded in cost of goods sold in the three and six months ended December 31, 2022 and 2021. | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table provides the balances and changes in accumulated other comprehensive income (loss) related to derivative instruments for the indicated periods: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Accumulated other comprehensive income beginning balance $ (170) $ (8,429) $ (1,692) $ (4,176) Net (gains) losses recognized from AOCI to earnings - Interest rate swap (6) (4) 386 (4) Net losses reclassified from AOCI to earnings for partial unwind of interest swap - Interest rate swap (273) (304) (952) (618) Net losses (gains) recognized in AOCI - Coffee-related 2,284 (5,132) 2,812 (10,991) Net gains recognized in earnings - Coffee-related 600 3,712 1,881 5,632 Accumulated other comprehensive income ending balance $ 2,435 $ (10,157) $ 2,435 $ (10,157) | |
Schedule of Offsetting Assets | The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2022 Derivative Assets $ 1,836 $ (566) $ — $ 1,270 Derivative Liabilities 5,352 (566) — 4,786 June 30, 2022 Derivative Assets 3,365 (2,349) — 1,016 Derivative Liabilities 2,349 (2,349) — — | |
Schedule of Offsetting Liabilities | The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2022 Derivative Assets $ 1,836 $ (566) $ — $ 1,270 Derivative Liabilities 5,352 (566) — 4,786 June 30, 2022 Derivative Assets 3,365 (2,349) — 1,016 Derivative Liabilities 2,349 (2,349) — — |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis | Assets and liabilities measured and recorded at fair value on a recurring basis were as follows: (In thousands) Total Level 1 Level 2 Level 3 December 31, 2022 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 271 $ — $ 271 $ — Coffee-related derivative liabilities (1) 885 — 885 — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) 295 — 295 — Coffee-related derivative liabilities (1) 4,467 — 4,467 — Interest rate swap derivative asset (2) 1,270 — 1,270 — Total Level 1 Level 2 Level 3 June 30, 2022 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 2,181 $ — $ 2,181 $ — Coffee-related derivative liabilities (1) 3 — 3 — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) 695 — 695 — Coffee-related derivative liabilities (1) 2,346 — 2,346 — Interest rate swap derivative asset (2) 489 — 489 — ____________________ (1) The Company's coffee-related derivative instruments are traded over-the-counter and, therefore, classified as Level 2. (2) The Company's interest rate swap derivative instrument are model-derived valuations with directly or indirectly observable significant inputs such as interest rate and, therefore, classified as Level 2. |
Accounts Receivable, Net (Table
Accounts Receivable, Net (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Receivables [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable | (In thousands) December 31, 2022 June 30, 2022 Trade receivables $ 49,132 $ 44,219 Other receivables (1) 1,371 2,911 Allowance for credit losses (190) (195) Accounts receivable, net $ 50,313 $ 46,935 __________ |
Inventories (Tables)
Inventories (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory, Current | (In thousands) December 31, 2022 June 30, 2022 Coffee Processed $ 21,934 $ 32,486 Unprocessed 34,273 39,326 Total $ 56,207 $ 71,812 Tea and culinary products Processed 22,969 24,034 Unprocessed 58 58 Total $ 23,027 $ 24,092 Coffee brewing equipment parts 4,303 3,714 Total inventories $ 83,537 $ 99,618 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | (In thousands) December 31, 2022 June 30, 2022 Buildings and facilities $ 93,038 $ 92,948 Machinery, vehicles and equipment 218,841 219,095 Capitalized software 12,170 25,467 Office furniture and equipment 12,049 14,347 $ 336,098 $ 351,857 Accumulated depreciation (213,425) (224,760) Land 11,053 11,053 Property, plant and equipment, net $ 133,726 $ 138,150 Coffee Brewing Equipment (“CBE”) and Service Capitalized CBE included in machinery and equipment above are: (In thousands) December 31, 2022 June 30, 2022 Coffee Brewing Equipment $ 93,934 $ 93,549 Accumulated depreciation (68,520) (68,938) Coffee Brewing Equipment, net $ 25,414 $ 24,611 Depreciation expense related to capitalized CBE and other CBE related expenses provided to customers and reported in cost of goods sold were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Depreciation expense in COGS $ 1,810 $ 1,905 $ 3,618 $ 3,869 CBE Costs excl. depreciation exp 7,215 5,702 14,419 11,750 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible Assets and Goodwill | The following is a summary of the Company’s amortized and unamortized intangible assets: December 31, 2022 June 30, 2022 (In thousands) Weighted Average Amortization Period as of December 31, 2022 Gross Carrying Accumulated Net Gross Carrying Accumulated Net Amortized intangible assets: Customer relationships 4.2 $ 33,003 $ (22,992) $ 10,011 $ 33,003 $ (21,893) $ 11,110 Recipes 0.8 930 (819) 111 930 (752) 178 Trade name/brand name 0.9 510 (476) 34 510 (457) 53 Total amortized intangible assets $ 34,443 $ (24,287) $ 10,156 $ 34,443 $ (23,102) $ 11,341 Unamortized intangible assets: Trademarks, trade names and brand name with indefinite lives $ 4,522 $ — $ 4,522 $ 4,522 $ — $ 4,522 Total unamortized intangible assets $ 4,522 $ — $ 4,522 $ 4,522 $ — $ 4,522 Total intangible assets $ 38,965 $ (24,287) $ 14,678 $ 38,965 $ (23,102) $ 15,863 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Schedule of Net Periodic Benefit Costs | The net periodic benefit (credit) cost for the defined benefit pension plans is as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Interest cost $ 1,156 $ 848 $ 2,312 $ 1,696 Expected return on plan assets (1,009) (1,237) (2,018) (2,474) Amortization of net loss (1) 281 339 563 678 Net periodic benefit (credit) cost $ 428 $ (50) $ 857 $ (100) ___________ (1) These amounts represent the estimated portion of the net loss in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year. Contributions made by the Company to the multiemployer pension plans were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Contributions to WCTPP $ 378 $ 226 $ 665 $ 471 Contributions to All Other Plans 8 10 16 17 The following table shows the components of net periodic postretirement benefit cost for the Retiree Medical Plan and Death Benefit Plan for the three and six months ended December 31, 2022 and 2021. Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2022 2021 2022 2021 Components of Net Periodic Postretirement Benefit Cost: Service cost $ — $ — $ — $ — Interest cost 10 7 19 13 Amortization of net gain — 3 — 6 Net periodic postretirement benefit cost $ 10 $ 10 $ 19 $ 19 |
Defined Benefit Plan, Assumptions | Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost December 31, 2022 June 30, 2022 Discount rate 4.50% 2.60% Expected long-term return on plan assets 6.50% 6.25% Weighted-Average Assumptions Used to Determine Net Periodic Postretirement Benefit Cost Fiscal year 2023 2022 Retiree Medical Plan discount rate N/A N/A Death Benefit Plan discount rate 4.77% 2.72% |
Debt Obligations (Tables)
Debt Obligations (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | The following table summarizes the Company’s debt obligations: December 31, 2022 June 30, 2022 (In thousands) Debt Origination Date Maturity Principal Borrowing Amount Carrying Value Weighted Average Interest Rate (1) Carrying Value Weighted Average Interest Rate Revolver Various 4/26/2027 N/A $ 67,000 5.05 % $ 63,000 2.75 % Term Loan 8/31/2022 4/26/2027 $47,000 46,217 45,600 113,217 108,600 Unamortized deferred debt financing costs (953) (1,677) Total $ 112,264 $ 106,923 __________ (1) The weighted average interest rate excludes the fixed rate on the de-designated Amended Rate Swap |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Share-based Compensation, Stock Options, Activity | The following table summarizes NQO activity for six months ended December 31, 2022: Outstanding NQOs: Number Weighted Weighted Aggregate Outstanding at June 30, 2022 450,687 12.39 4.34 $ — Granted — — — — Exercised — — — — Cancelled/Forfeited (11,807) 15.94 — — Expired (27,973) 19.77 — — Outstanding at December 31, 2022 410,907 11.79 3.83 $ — Exercisable at December 31, 2022 366,929 12.30 3.78 $ — The following table summarizes PNQ activity for the six months ended December 31, 2022: Outstanding PNQs: Number Weighted Weighted Aggregate Outstanding at June 30, 2022 2,212 30.91 0.83 $ — Granted — — — — Exercised — — — — Cancelled/Forfeited — — — — Expired (1,221) 29.48 — — Outstanding at December 31, 2022 991 32.84 0.86 $ — Exercisable at December 31, 2022 991 32.84 0.86 $ — |
Schedule of Share-based Compensation, Nonvested Restricted Stock Shares Activity | The following table summarizes restricted stock activity for the six months ended December 31, 2022: Outstanding and Nonvested Restricted Stock Awards: Shares Weighted Average Outstanding and nonvested at June 30, 2022 816,811 6.67 Granted 486,196 6.15 Vested/Released (312,925) 6.64 Cancelled/Forfeited (80,395) 6.15 Outstanding and nonvested at December 31, 2022 909,687 6.56 The following table summarizes CSRSU activity for the six months ended December 31, 2022: Outstanding and Nonvested CSRSUs: CSRSUs Weighted Average Outstanding and nonvested at June 30, 2022 145,645 6.36 Granted 178,099 6.40 Vested/Released (42,670) 6.24 Cancelled/Forfeited (55,351) 6.10 Outstanding and nonvested at December 31, 2022 225,723 6.47 |
Schedule of Nonvested Performance-Based Restricted Stock Units Activity | The following table summarizes PBRSU activity for the six months ended December 31, 2022: Outstanding and Nonvested PBRSUs: PBRSUs Weighted Average Outstanding and nonvested at June 30, 2022 456,993 6.16 Granted (1) 214,842 6.40 Vested/Released — — Cancelled/Forfeited (19,540) 15.35 Outstanding and nonvested at December 31, 2022 652,295 5.96 _____________ (1) The target number of PBRSUs is presented in the table. Under the terms of the awards, the recipient may earn between 0% and 200% of the target number of PBRSUs depending on the extent to which the Company meets or exceeds the achievement of the applicable financial performance goals. |
Other Current Liabilities (Tabl
Other Current Liabilities (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Schedule of Other Current Liabilities | Other current liabilities consist of the following: (In thousands) December 31, 2022 June 30, 2022 Accrued workers’ compensation liabilities $ 851 $ 947 Finance lease liabilities 193 193 Other (1) 4,582 4,955 Other current liabilities $ 5,626 $ 6,095 _________ (1) Includes accrued property taxes, sales and use taxes and insurance liabilities. |
Other Long-Term Liabilities (Ta
Other Long-Term Liabilities (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Other Liabilities Disclosure [Abstract] | |
Other Long-Term Liabilities | Other long-term liabilities include the following: (In thousands) December 31, 2022 June 30, 2022 Deferred compensation (1) $ 255 $ 195 Finance lease liabilities 347 409 Deferred income taxes and other liabilities 735 735 Other long-term liabilities $ 1,337 $ 1,339 ___________ (1) Includes payroll taxes and cash-settled restricted stock units liabilities. |
Income Taxes (Tables)
Income Taxes (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Tax | The income tax expense and the related effective tax rates are as follows (in thousands, except effective tax rate): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Income tax expense $ 40 $ 126 $ 83 $ 188 Effective tax rate (0.3) % (2.4) % (0.4) % (2.5) % |
Net Loss Per Common Share (Tabl
Net Loss Per Common Share (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings (Loss) Per Common Share, Basic and Diluted | The following table presents the computation of basic and diluted net earnings loss per common share: Three Months Ended December 31, Six Months Ended December 31, (In thousands, except share and per share amounts) 2022 2021 2022 2021 Undistributed net loss available to common stockholders $ (13,608) $ (5,334) $ (20,982) $ (7,830) Undistributed net loss available to nonvested restricted stockholders and holders of convertible preferred stock — (234) — (309) Net loss available to common stockholders - basic $ (13,608) $ (5,568) $ (20,982) $ (8,139) Weighted average common shares outstanding - basic 18,723,957 18,106,151 19,243,707 18,034,658 Effect of dilutive securities: Shares issuable under stock options — — — — Weighted average common shares outstanding - diluted 18,723,957 18,106,151 19,243,707 18,034,658 Net loss available to common stockholders per common share—basic $ (0.73) $ (0.31) $ (1.09) $ (0.45) Net loss available to common stockholders per common share—diluted $ (0.73) $ (0.31) $ (1.09) $ (0.45) The following table summarizes weighted average anti-dilutive securities excluded from the computation of diluted net loss per common share for the periods indicated: Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Shares issuable under stock options 410,907 481,429 410,907 487,088 Shares issuable under convertible preferred stock — 444,849 — 444,849 Shares issuable under PBRSUs 501,141 498,210 469,297 437,211 |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The Company disaggregates net sales from contracts with customers based on the characteristics of the products sold: Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 (In thousands) $ % of total $ % of total $ % of total $ % of total Net Sales by Product Category: Coffee (Roasted) $ 82,725 62.3 % $ 75,506 63.8 % $ 161,019 63.4 % $ 146,104 64.4 % Tea & Other Beverages (1) 26,686 20.2 % 22,891 19.3 % 47,632 18.7 % 41,928 18.5 % Culinary 16,372 12.3 % 13,913 11.7 % 31,269 12.3 % 26,988 11.9 % Spices 5,709 4.3 % 5,059 4.3 % 11,733 4.6 % 10,258 4.5 % Net sales by product category 131,492 99.1 % 117,369 99.1 % 251,653 99.0 % 225,278 99.3 % Delivery Surcharge 1,200 0.9 % 1,076 0.9 % 2,420 1.0 % 1,529 0.7 % Net sales $ 132,692 100.0 % $ 118,445 100.0 % $ 254,073 100.0 % $ 226,807 100.0 % ____________ (1) Includes all beverages other than roasted coffee, including frozen liquid coffee, and iced and hot tea, including cappuccino, cocoa, granitas, and concentrated and ready-to drink cold brew and iced coffee. |
Sales of Assets (Tables)
Sales of Assets (Tables) | 6 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets held-for-sale | During the six months ended December 31, 2022, the Company completed the sale of the following branch properties: (In thousands) Name of Branch Property Date Sold Sales Price Net Proceeds Gain on Sale Portland, Oregon 9/23/2022 $ 1,990 $ 1,880 $ 1,770 San Diego, California 9/19/2022 7,574 7,169 6,425 Fresno, California 10/7/2022 760 716 648 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |
Sep. 30, 2022 | Dec. 31, 2022 | Jun. 30, 2022 | |
Property, Plant and Equipment | |||
Cash and cash equivalents | $ 17,624 | $ 9,819 | |
Restricted cash | $ 2,316 | $ 175 | |
Accounts Receivable | Five Customers | Customer Concentration Risk | |||
Property, Plant and Equipment | |||
% of total | 35% | 36% |
Leases - Narrative (Details)
Leases - Narrative (Details) | Dec. 31, 2022 |
Leases [Abstract] | |
Lessee, Operating Lease, Renewal Term | 10 years |
Leases - Lease Expense (Details
Leases - Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | ||||
Operating lease expense | $ 1,986 | $ 1,888 | $ 3,946 | $ 3,670 |
Amortization of finance lease assets | 41 | 41 | 82 | 82 |
Interest on finance lease liabilities | 9 | 11 | 18 | 23 |
Total lease expense | $ 2,036 | $ 1,940 | $ 4,046 | $ 3,775 |
Leases - Lease Obligations (Det
Leases - Lease Obligations (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Operating Leases | |
2023 | $ 4,001 |
2024 | 7,829 |
2025 | 6,650 |
2026 | 5,567 |
2027 | 4,127 |
Thereafter | 4,008 |
Total lease payments | 32,182 |
Less: interest | (4,270) |
Total lease obligations | 27,912 |
Finance Leases | |
2023 | 96 |
2024 | 193 |
2025 | 193 |
2026 | 96 |
2027 | 0 |
Thereafter | 0 |
Total lease payments | 578 |
Less: interest | (54) |
Total lease obligations | $ 524 |
Leases - Weighted Average Infor
Leases - Weighted Average Information (Details) | Dec. 31, 2022 | Jun. 30, 2022 |
Leases [Abstract] | ||
Operating lease | 6 years 3 months 18 days | 6 years 3 months 18 days |
Finance lease | 3 years | 3 years 6 months |
Operating lease | 6% | 5.69% |
Finance lease | 6.50% | 6.50% |
Leases - Cash Flow Information
Leases - Cash Flow Information (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | ||
Operating cash flows from operating leases | $ 3,882 | $ 3,351 |
Operating cash flows from finance leases | 18 | 73 |
Financing cash flows from finance leases | $ 96 | $ 23 |
Derivative Instruments - Schedu
Derivative Instruments - Schedule of Notional Volumes of Derivative Instruments (Details) - lb | Dec. 31, 2022 | Jun. 30, 2022 |
Derivative [Line Items] | ||
Total | 7,327,000 | 4,716,000 |
Cash Flow Hedging | Designated as Hedging Instrument | Long | ||
Derivative [Line Items] | ||
Total | 3,638,000 | 4,200,000 |
Cash Flow Hedging | Not Designated as Hedging Instrument | Long | ||
Derivative [Line Items] | ||
Total | 8,377,000 | 516,000 |
Derivative Instruments - Fair V
Derivative Instruments - Fair Value of Derivative Instruments on the Consolidated Balance Sheets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Short-term derivative assets: | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | $ 295 | $ 555 |
Short-term derivative assets: | Not Designated as Hedging Instrument | Interest Rate Swap | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 1,270 | 323 |
Short-term derivative assets: | Cash Flow Hedging | Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 271 | 2,144 |
Short-term derivative assets: | Cash Flow Hedging | Designated as Hedging Instrument | Interest Rate Swap | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 0 | 0 |
Long-term derivative assets: | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 0 | 140 |
Long-term derivative assets: | Not Designated as Hedging Instrument | Interest Rate Swap | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 0 | 166 |
Long-term derivative assets: | Cash Flow Hedging | Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 0 | 37 |
Long-term derivative assets: | Cash Flow Hedging | Designated as Hedging Instrument | Interest Rate Swap | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 0 | 0 |
Short-term derivative liabilities: | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | 4,467 | 2,346 |
Short-term derivative liabilities: | Cash Flow Hedging | Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | $ 885 | $ 3 |
Derivative Instruments - Pretax
Derivative Instruments - Pretax Effect of Derivative Instruments on Earnings and OCI (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cost of goods sold | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
AOCI reclassification into interest expense | $ 0 | |||
Interest Rate Swap | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Net (gains) losses recognized from AOCI to earnings - Interest rate swap | $ (6,000) | $ (4,000) | 386,000 | $ (4,000) |
Net losses reclassified from AOCI to earnings for de-designated Interest rate swap | (273,000) | (304,000) | (952,000) | (618,000) |
AOCI reclassification into interest expense | (300,000) | (600,000) | ||
Coffee - related | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
AOCI reclassification into interest expense | (2,284,000) | 5,132,000 | (2,812,000) | 10,991,000 |
Coffee - related | Cost of goods sold | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
AOCI reclassification into interest expense | $ 600,000 | $ 3,712,000 | $ 1,881,000 | $ 5,632,000 |
Derivative Instruments - Narrat
Derivative Instruments - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | Apr. 26, 2021 | Mar. 27, 2019 | |
Derivative [Line Items] | ||||||
Derivative Instruments, Percentage Designated As Cash Flow Hedges | 50% | 50% | 89% | |||
Cash flow hedge gain (loss) to be reclassified within twelve months | $ 800,000 | |||||
Cost of goods sold | ||||||
Derivative [Line Items] | ||||||
AOCI reclassification into interest expense | $ 0 | |||||
Cash Flow Hedging | ||||||
Derivative [Line Items] | ||||||
Derivative, Term of Contract | 12 months | |||||
Cash Flow Hedging | Cost of goods sold | ||||||
Derivative [Line Items] | ||||||
AOCI reclassification into interest expense | $ 0 | |||||
Interest Rate Swap | ||||||
Derivative [Line Items] | ||||||
Derivative, Notional Amount | $ 65,000,000 | $ 65,000,000 | $ 80,000,000 | |||
Derivative, Fixed Interest Rate | 2.1975% | 2.1975% | 2.4725% | |||
AOCI reclassification into interest expense | $ (300,000) | $ (600,000) | ||||
Derivative Instrument, To Be Amortized | $ 800,000 | $ 800,000 | ||||
Interest Rate Swap | Minimum | ||||||
Derivative [Line Items] | ||||||
Derivative, Floor Interest Rate | 0% | 0% | ||||
Coffee-related Derivative Instruments | ||||||
Derivative [Line Items] | ||||||
Cash flow hedge gain (loss) to be reclassified within twelve months | $ (1,500,000) |
Derivative Instruments - Net Re
Derivative Instruments - Net Realized and Unrealized Gains and Losses Recorded in "Other, net" (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Other, net | $ (3,270) | $ 1,767 | $ (1,662) | $ 4,211 |
Coffee | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Net gains on coffee-related derivative instruments | (4,167) | 872 | (3,605) | 2,422 |
Non-operating pension and other postretirement benefits | 727 | 895 | 1,455 | 1,789 |
Other gains, net | 170 | 0 | 488 | 0 |
Other, net | $ (3,270) | $ 1,767 | $ (1,662) | $ 4,211 |
Derivative Instruments - Statem
Derivative Instruments - Statement of Comprehensive Income (Loss) (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Stockholders' Equity Attributable to Parent | $ 82,938,000 | $ 105,310,000 | $ 82,938,000 | $ 105,310,000 | $ 96,849,000 | $ 104,748,000 | $ 108,033,000 | $ 104,959,000 |
Derivative Instruments | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Stockholders' Equity Attributable to Parent | 2,435,000 | (10,157,000) | 2,435,000 | (10,157,000) | $ (170,000) | $ (1,692,000) | $ (8,429,000) | $ (4,176,000) |
Derivative Instruments | Partial Unwind of Interest Swap | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Net gains (losses) recognized in earnings | (273,000) | (304,000) | (952,000) | (618,000) | ||||
Derivative Instruments | Coffee - related | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Net gains (losses) recognized in earnings | 600,000 | 3,712,000 | 1,881,000 | 5,632,000 | ||||
Net gains (losses) recognized in AOCI | 2,284,000 | (5,132,000) | 2,812,000 | (10,991,000) | ||||
Derivative Instruments | Interest Rate Swap | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Net gains (losses) recognized in earnings | $ (6,000) | $ (4,000) | $ 386,000 | $ (4,000) |
Derivative Instruments - Sche_2
Derivative Instruments - Schedule of Offsetting Derivative Asset and Liability Positions (Details) - Counterparty A - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | $ 1,836 | $ 3,365 |
Derivative asset, netting adjustment | (566) | (2,349) |
Derivative asset, cash collateral posted | 0 | 0 |
Derivative asset, net | 1,270 | 1,016 |
Derivative liability, fair value | 5,352 | 2,349 |
Derivative liability, netting adjustment | (566) | (2,349) |
Derivative liability, cash collateral posted | 0 | 0 |
Derivative liability, net | $ 4,786 | $ 0 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - Estimate of Fair Value Measurement - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Designated as Hedging Instrument | Coffee-related Derivative Instruments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | $ 271 | $ 2,181 |
Coffee-related derivative liabilities | 885 | 3 |
Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | 0 |
Coffee-related derivative liabilities | 0 | 0 |
Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 271 | 2,181 |
Coffee-related derivative liabilities | 885 | 3 |
Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | 0 |
Coffee-related derivative liabilities | 0 | 0 |
Not Designated as Hedging Instrument | Coffee-related Derivative Instruments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 295 | 695 |
Coffee-related derivative liabilities | 2,346 | |
Not Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | 0 |
Coffee-related derivative liabilities | 0 | |
Not Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 295 | 695 |
Coffee-related derivative liabilities | 2,346 | |
Not Designated as Hedging Instrument | Coffee-related Derivative Instruments | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | 0 |
Coffee-related derivative liabilities | 0 | |
Not Designated as Hedging Instrument | Interest Rate Swap | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 1,270 | 489 |
Coffee-related derivative liabilities | 4,467 | |
Not Designated as Hedging Instrument | Interest Rate Swap | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | 0 |
Coffee-related derivative liabilities | 0 | |
Not Designated as Hedging Instrument | Interest Rate Swap | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 1,270 | 489 |
Coffee-related derivative liabilities | 4,467 | |
Not Designated as Hedging Instrument | Interest Rate Swap | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Coffee-related derivative assets | 0 | $ 0 |
Coffee-related derivative liabilities | $ 0 |
Accounts Receivable, Net (Detai
Accounts Receivable, Net (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Receivables [Abstract] | ||
Trade receivables | $ 49,132 | $ 44,219 |
Other receivables | 1,371 | 2,911 |
Allowance for credit losses | (190) | (195) |
Accounts receivable, net | $ 50,313 | $ 46,935 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Product Information | ||
Total | $ 83,537 | $ 99,618 |
Coffee | ||
Product Information | ||
Processed | 21,934 | 32,486 |
Unprocessed | 34,273 | 39,326 |
Total | 56,207 | 71,812 |
Tea and Culinary Products | ||
Product Information | ||
Processed | 22,969 | 24,034 |
Unprocessed | 58 | 58 |
Total | 23,027 | 24,092 |
Coffee Brewing Equipment | ||
Product Information | ||
Total | $ 4,303 | $ 3,714 |
Property, Plant and Equipment_2
Property, Plant and Equipment (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | |
Property, Plant and Equipment | |||||
Property, plant and equipment gross | $ 336,098 | $ 336,098 | $ 351,857 | ||
Accumulated depreciation | (213,425) | (213,425) | (224,760) | ||
Land | 11,053 | 11,053 | 11,053 | ||
Property, plant and equipment, net | 133,726 | 133,726 | 138,150 | ||
Building and Facilities | |||||
Property, Plant and Equipment | |||||
Property, plant and equipment gross | 93,038 | 93,038 | 92,948 | ||
Machinery and Equipment | |||||
Property, Plant and Equipment | |||||
Property, plant and equipment gross | 218,841 | 218,841 | 219,095 | ||
Capitalized Software Costs | |||||
Property, Plant and Equipment | |||||
Property, plant and equipment gross | 12,170 | 12,170 | 25,467 | ||
Office furniture and equipment | |||||
Property, Plant and Equipment | |||||
Property, plant and equipment gross | 12,049 | 12,049 | 14,347 | ||
Coffee Brewing Equipment | |||||
Property, Plant and Equipment | |||||
Property, plant and equipment gross | 93,934 | 93,934 | 93,549 | ||
Accumulated depreciation | (68,520) | (68,520) | (68,938) | ||
Property, plant and equipment, net | 25,414 | 25,414 | $ 24,611 | ||
Depreciation | 1,810 | $ 1,905 | 3,618 | $ 3,869 | |
Other Expenses | $ 7,215 | $ 5,702 | $ 14,419 | $ 11,750 |
Intangible Assets - Schedule of
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Dec. 31, 2022 | Jun. 30, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||
Accumulated Amortization | $ (24,287) | $ (23,102) |
Finite-Lived Intangible Assets, Net | 14,678 | 15,863 |
Total intangible assets | 38,965 | 38,965 |
Trademarks, trade names and brand name with indefinite lives | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Net | 4,522 | 4,522 |
Unamortized intangible assets, Gross Carrying Amount | 4,522 | 4,522 |
Total unamortized intangible assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Net | 4,522 | 4,522 |
Unamortized intangible assets, Gross Carrying Amount | $ 4,522 | 4,522 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, weighted average useful life | 4 years 2 months 12 days | |
Amortized intangible assets, Gross Carrying Amount | $ 33,003 | 33,003 |
Accumulated Amortization | (22,992) | (21,893) |
Finite-Lived Intangible Assets, Net | $ 10,011 | 11,110 |
Recipes | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, weighted average useful life | 9 months 18 days | |
Amortized intangible assets, Gross Carrying Amount | $ 930 | 930 |
Accumulated Amortization | (819) | (752) |
Finite-Lived Intangible Assets, Net | $ 111 | 178 |
Trade name/brand name | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, weighted average useful life | 10 months 24 days | |
Amortized intangible assets, Gross Carrying Amount | $ 510 | 510 |
Accumulated Amortization | (476) | (457) |
Finite-Lived Intangible Assets, Net | 34 | 53 |
Total amortized intangible assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Amortized intangible assets, Gross Carrying Amount | 34,443 | 34,443 |
Accumulated Amortization | (24,287) | (23,102) |
Finite-Lived Intangible Assets, Net | $ 10,156 | $ 11,341 |
Intangible Assets - Narrative (
Intangible Assets - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization expense | $ 0.6 | $ 0.6 | $ 1.2 | $ 1.2 |
Employee Benefit Plans - Schedu
Employee Benefit Plans - Schedule of Single Employer Pension Plans (Details) - Pension Plan - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Components of net periodic benefit cost | ||||
Interest cost | $ 1,156 | $ 848 | $ 2,312 | $ 1,696 |
Expected return on plan assets | (1,009) | (1,237) | (2,018) | (2,474) |
Amortization of net loss (gain) | 281 | 339 | 563 | 678 |
Net periodic benefit cost | $ 428 | $ (50) | $ 857 | $ (100) |
Weighted average assumptions used to determine benefit obligations | ||||
Discount rate | 4.50% | 2.60% | ||
Expected long-term return on plan assets | 6.50% | 6.25% |
Employee Benefit Plans - Narrat
Employee Benefit Plans - Narrative (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||||||
Jan. 01, 2023 | Jan. 01, 2022 shares | Jan. 31, 2022 | Jul. 31, 2021 | Dec. 31, 2022 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) shares | Dec. 31, 2022 USD ($) plan hour $ / shares shares | Dec. 31, 2021 USD ($) shares | Jun. 30, 2022 $ / shares | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||
Defined Contribution Plan, Employer Discretionary Contribution Amount | $ 600 | $ 500 | $ 1,100 | $ 1,100 | ||||||
Amortization expense | $ 600 | 600 | $ 1,200 | 1,200 | ||||||
Defined Contribution Plan, Number of Hours Threshold | hour | 1,000 | |||||||||
Defined Contribution Plan, Employer Matching Contribution, Percentage of Employee Contribution | 6% | 6% | ||||||||
Common stock, par value (in US$ per share) | $ / shares | $ 1 | $ 1 | $ 1 | |||||||
Employer Contribution Plan, Increase In Shares Available | shares | 2,000,000 | |||||||||
Defined Contribution Plan, Employer Matching Contribution, Percentage of Employee Contribution, Non-Union | 50% | 50% | ||||||||
First Threshold | ||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||
Maximum annual contribution per an employee, percent | 3% | |||||||||
Defined Contribution Plan, Employer Matching Contribution, Percent of Match | 100% | |||||||||
Second Threshold | ||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||
Defined contribution plan, employer matching contribution, percent of eligible income | 50% | |||||||||
Maximum annual contribution per an employee, percent | 2% | |||||||||
Other Postretirement Benefit Plan | ||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||
Multiemployer plans, number of plans | plan | 9 | |||||||||
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment | $ 0 | 3 | $ 0 | 6 | ||||||
Contributions made by the Company to the multiemployer pension plans | 8 | 10 | 16 | 17 | ||||||
Restated and Amended 401K Plan | ||||||||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||||||||
Defined Contribution Plan, Employer Discretionary Contribution Amount | $ 600 | $ 700 | $ 1,200 | $ 1,300 | ||||||
Defined contribution plan, employer matching contribution, percent of eligible income | 4% | |||||||||
Defined Contribution Plan, Number of Shares Contributed | shares | 264,712 | 82,437 | 521,764 | 134,034 |
Employee Benefit Plans - Sche_2
Employee Benefit Plans - Schedule of Multi-Employer Pension Plans (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Multiemployer Plan | ||||
Multiemployer Plans [Line Items] | ||||
Contributions made by the Company to the multiemployer pension plans | $ 378 | $ 226 | $ 665 | $ 471 |
Other Postretirement Benefit Plan | ||||
Multiemployer Plans [Line Items] | ||||
Contributions made by the Company to the multiemployer pension plans | 8 | 10 | 16 | 17 |
Service cost | 0 | 0 | 0 | 0 |
Interest cost | 10 | 7 | 19 | 13 |
Amortization of net gain | 0 | (3) | 0 | (6) |
Net periodic benefit cost | $ 10 | $ 10 | $ 19 | $ 19 |
Postretirement Life Insurance | ||||
Multiemployer Plans [Line Items] | ||||
Discount rate | 4.77% | 2.72% |
Debt Obligations (Details)
Debt Obligations (Details) | 3 Months Ended | 6 Months Ended | ||||||
Aug. 31, 2022 USD ($) | Aug. 30, 2022 | Aug. 08, 2022 USD ($) | Apr. 26, 2021 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | Mar. 27, 2019 USD ($) | |
Line of Credit Facility | ||||||||
Long-term Line of Credit, Noncurrent | $ 67,000,000 | $ 67,000,000 | $ 63,000,000 | |||||
Long-term Debt, Gross | 113,217,000 | 113,217,000 | 108,600,000 | |||||
Quarterly Debt Payments | 261,000 | |||||||
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | (953,000) | (953,000) | (1,677,000) | |||||
Long-Term Debt | 112,264,000 | 112,264,000 | $ 106,923,000 | |||||
Revolving Credit Facility | ||||||||
Line of Credit Facility | ||||||||
Long-term Line of Credit, Noncurrent | $ 67,000,000 | $ 67,000,000 | ||||||
Debt, Weighted Average Interest Rate | 5.05% | 5.05% | 2.75% | |||||
Line of credit, maximum borrowing capacity | $ 90,000,000 | |||||||
Long-term Debt, Gross | $ 67,000,000 | $ 67,000,000 | $ 63,000,000 | |||||
Long-term Line of Credit | 14,300,000 | 14,300,000 | ||||||
Line Of Credit Facility, Increase In Borrowing Capacity | $ 10,000,000 | |||||||
Letter of Credit | ||||||||
Line of Credit Facility | ||||||||
Long-term Line of Credit | $ 4,100,000 | $ 4,100,000 | ||||||
Revolver Security Agreement | ||||||||
Line of Credit Facility | ||||||||
Debt Instrument, Borrowing Base, Accounts Receivable | 85% | |||||||
Debt Instrument, Borrowing Base, Inventory | 80% | |||||||
Revolver Security Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | ||||||||
Line of Credit Facility | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.75% | |||||||
Revolver Security Agreement | Maximum | LIBOR | ||||||||
Line of Credit Facility | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 2.25% | |||||||
Revolver Security Agreement | Revolving Credit Facility | ||||||||
Line of Credit Facility | ||||||||
Line of credit, maximum borrowing capacity | $ 80,000,000 | |||||||
Revolver Security Agreement | Revolving Credit Facility | Line of Credit | ||||||||
Line of Credit Facility | ||||||||
Line of credit, maximum borrowing capacity | $ 47,000,000 | |||||||
Amortization of Debt Issuance Costs and Discounts | $ 1,500,000 | |||||||
Debt Instrument, Covenant, Fixed Charge Coverage Ratio | 1 | |||||||
Letter Of Credit Fee Payable | 1.75% | 2.25% | ||||||
Term Credit Facility Agreement | Revolving Credit Facility | ||||||||
Line of Credit Facility | ||||||||
Line of credit, maximum borrowing capacity | 47,500,000 | |||||||
Debt Instrument, Periodic Payment, Principal | $ 950,000 | |||||||
Term Loan | ||||||||
Line of Credit Facility | ||||||||
Debt, Weighted Average Interest Rate | ||||||||
Long-term Debt, Gross | $ 46,217,000 | $ 46,217,000 | $ 45,600,000 | |||||
Term Loan | Senior Loans | ||||||||
Line of Credit Facility | ||||||||
Long-term Line of Credit | 47,000,000 | 47,000,000 | ||||||
Interest Rate Swap | ||||||||
Line of Credit Facility | ||||||||
Derivative, Notional Amount | $ 65,000,000 | $ 65,000,000 | $ 80,000,000 | |||||
Derivative, Fixed Interest Rate | 2.4725% | 2.1975% | 2.1975% | |||||
Derivative, Fixed Interest Rate Increase During Period | 0.275% | |||||||
Interest Rate Swap | Minimum | ||||||||
Line of Credit Facility | ||||||||
Derivative, Floor Interest Rate | 0% | 0% |
Share-Based Compensation - Perf
Share-Based Compensation - Performance-Based RSUs (Details) | 6 Months Ended | |
Dec. 31, 2022 $ / shares shares | Jun. 30, 2022 $ / shares | |
Performance Based Restricted Stock Units | Minimum | ||
Number of PBRSUs [Roll Forward] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 0% | |
Performance Based Restricted Stock Units | Maximum | ||
Number of PBRSUs [Roll Forward] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 200% | |
Performance Based Restricted Stock Units | ||
Number of PBRSUs [Roll Forward] | ||
Shares Awarded, Beginning balance (in shares) | 456,993 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 214,842 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 19,540 | |
Shares Awarded, Ending balance (in shares) | 652,295 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares | $ 5.96 | $ 6.16 |
Weighted average grant date fair value, RSUs (dollars per share) | $ / shares | 6.40 | |
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | $ / shares | 0 | |
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ / shares | $ 15.35 |
Share-Based Compensation - Narr
Share-Based Compensation - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $ 32,700 | $ 32,700 | $ 200,000 | ||
Restricted Stock | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | 5,000,000 | 5,000,000 | 3,900,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | 3,200,000 | ||||
Restricted Stock | General and Administrative Expense | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Compensation expense recognized | 700,000 | $ 600,000 | 1,400,000 | $ 1,000,000 | |
Performance-Based Restricted Stock Units (PBRSUs) | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Compensation expense recognized | 200,000 | 183,600 | 400,000 | 300,000 | |
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | $ 2,600,000 | 2,600,000 | $ 1,700,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $ 1,400,000 | ||||
Performance Based Restricted Stock Units | Minimum | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 0% | ||||
Performance Based Restricted Stock Units | Maximum | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 200% | ||||
Cash-Settled Restricted Stock Units | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $ 1,100,000 | ||||
2017 Plan | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Common Stock, Capital Shares Reserved for Future Issuance | 1,455,761 | 1,455,761 | |||
2020 Inducement Plan | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Common Stock, Capital Shares Reserved for Future Issuance | 60,475 | 60,475 | |||
NQOs | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share price (in US$ per share) | $ 4.61 | $ 4.61 | $ 4.69 | ||
Compensation expense recognized | $ 23,500 | $ 200,000 | $ 100,000 | $ 300,000 | |
NQOs | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period | 4 months | ||||
Restricted Stock | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Weighted average grant date fair value, RSUs (dollars per share) | $ 6.15 | $ 8.22 | |||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ 1,600,000 | $ 2,200,000 | |||
Restricted Stock | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period | 2 years 2 months 12 days | ||||
Performance-Based Restricted Stock Units (PBRSUs) | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period | 2 years 1 month 6 days | ||||
Weighted average grant date fair value, RSUs (dollars per share) | $ 6.40 | $ 8.91 | |||
CSRSU | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $ 1,000,000 | $ 1,000,000 | $ 600,000 | ||
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period | 2 years 6 months | ||||
Employee Benefits and Share-based Compensation | $ 100,000 | $ 100,000 | $ 100,000 | 100,000 | |
Cash-settled Restricted Stock | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period | 3 years | ||||
Weighted average grant date fair value, RSUs (dollars per share) | $ 6.40 | ||||
Cash-Settled Restricted Stock Units | |||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs | |||||
Weighted average grant date fair value, RSUs (dollars per share) | $ 6.40 | $ 8.91 | |||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ 200,000 | $ 400,000 |
Share-Based Compensation - Stoc
Share-Based Compensation - Stock Option Activity NQOs and PNQs (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | |
NQOs | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||||
Number of options granted (shares) | 0 | |||
Number of options exercised (shares) | 0 | |||
Number of options cancelled/forfeited (shares) | (11,807) | |||
Number of options expired (shares) | (27,973) | |||
Number of options - Ending balance (in shares) | 410,907 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ||||
Weighted average purchase price (in US$ per share) | $ 0 | |||
Weighted Average Exercise Price, Exercised (in US$ per share) | 0 | |||
Weighted Average Exercise Price, Cancelled/Forfeited (in US$ per share) | 15.94 | |||
Weighted Average Exercise Price, Expired (in US$ per share) | 19.77 | |||
Weighted Average Exercise Price, Ending balance (in US$ per share) | $ 11.79 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||||
Weighted Average Remaining Life, Beginning balance | 3 years 9 months 29 days | |||
Weighted Average Remaining Life, Ending balance | 3 years 9 months 29 days | |||
Aggregate Intrinsic Value, Beginning balance | $ 0 | |||
Aggregate intrinsic value, exercised | $ 0 | |||
PNQs | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||||
Weighted Average Remaining Life, Beginning balance | 10 months 9 days | |||
Weighted Average Remaining Life, Ending balance | 10 months 9 days | |||
PNQs | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||||
Number of options - Beginning balance (in shares) | 2,212 | |||
Number of options granted (shares) | 0 | |||
Number of options exercised (shares) | 0 | |||
Number of options cancelled/forfeited (shares) | 0 | |||
Number of options expired (shares) | (1,221) | |||
Number of options - Ending balance (in shares) | 991 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ||||
Weighted Average Exercise Price, Beginning balance (in US$ per share) | $ 30.91 | |||
Weighted average purchase price (in US$ per share) | 0 | |||
Weighted Average Exercise Price, Exercised (in US$ per share) | 0 | |||
Weighted Average Exercise Price, Cancelled/Forfeited (in US$ per share) | 0 | |||
Weighted Average Exercise Price, Expired (in US$ per share) | 29.48 | |||
Weighted Average Exercise Price, Ending balance (in US$ per share) | $ 32.84 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||||
Weighted Average Remaining Life, Beginning balance | 9 months 29 days | |||
Weighted Average Remaining Life, Ending balance | 9 months 29 days | |||
Aggregate Intrinsic Value, Beginning balance | $ 0 | |||
Aggregate intrinsic value, exercised | $ 0 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] | ||||
Options, Vested and exercisable, Outstanding (in shares) | 991 | |||
Options, Vested and exercisable, Weighted Average Exercise Price (in US$ per share) | $ 32.84 | |||
Options, Vested and exercisable, Weighted Average Remaining Contractual Term | 10 months 9 days | |||
Vested | NQOs | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||||
Number of options - Beginning balance (in shares) | 450,687 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ||||
Weighted Average Exercise Price, Beginning balance (in US$ per share) | $ 12.39 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||||
Weighted Average Remaining Life, Beginning balance | 4 years 4 months 2 days | |||
Weighted Average Remaining Life, Ending balance | 4 years 4 months 2 days | |||
Aggregate Intrinsic Value, Beginning balance | $ 0 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] | ||||
Options, Vested and exercisable, Outstanding (in shares) | 366,929 | |||
Options, Vested and exercisable, Weighted Average Exercise Price (in US$ per share) | $ 12.30 | |||
Options, Vested and exercisable, Weighted Average Remaining Contractual Term | 3 years 9 months 10 days | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ 0 |
Share-Based Compensation - Rest
Share-Based Compensation - Restricted Stock Activity (Details) - Restricted Stock - $ / shares | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | |
Number of Restricted Stock [Roll Forward] | |||
Shares Awarded, Beginning balance (in shares) | 816,811 | ||
Restricted stock granted (in shares) | 486,196 | ||
Shares Awarded, Exercised/Released (in shares) | (312,925) | ||
Shares Awarded, Cancelled/Forfeited (in shares) | (80,395) | ||
Shares Awarded, Ending balance (in shares) | 909,687 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 6.56 | $ 6.67 | |
Restricted stock granted, weighted average grant date fair value (in US$ per share) | 6.15 | $ 8.22 | |
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | 6.64 | ||
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ 6.15 |
Share-Based Compensation - Cash
Share-Based Compensation - Cash Settled Restricted Stock (Details) - Cash-settled Restricted Stock - $ / shares | 6 Months Ended | |
Dec. 31, 2022 | Jun. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 225,723 | 145,645 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 6.47 | $ 6.36 |
Restricted stock granted (in shares) | 178,099 | |
Weighted average grant date fair value, RSUs (dollars per share) | $ 6.40 | |
Shares Awarded, Exercised/Released (in shares) | (42,670) | |
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | $ 6.24 | |
Shares Awarded, Cancelled/Forfeited (in shares) | (55,351) | |
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ 6.10 |
Other Current Liabilities (Deta
Other Current Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Payables and Accruals [Abstract] | ||
Accrued workers’ compensation liabilities | $ 851 | $ 947 |
Finance lease liabilities | 193 | 193 |
Other | 4,582 | 4,955 |
Other current liabilities | $ 5,626 | $ 6,095 |
Other Long-Term Liabilities (De
Other Long-Term Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jun. 30, 2022 |
Other Liabilities Disclosure [Abstract] | ||
Deferred compensation | $ 255 | $ 195 |
Finance lease liabilities | 347 | 409 |
Deferred income taxes | 735 | 735 |
Other long-term liabilities | $ 1,337 | $ 1,339 |
Income Taxes - Income Taxes (De
Income Taxes - Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 40 | $ 126 | $ 83 | $ 188 |
Effective tax rate | (0.30%) | (2.40%) | (0.40%) | (2.50%) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 40 | $ 126 | $ 83 | $ 188 |
Net Loss Per Common Share (Deta
Net Loss Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Undistributed Earnings (Loss) Available to Common Shareholders, Basic | $ (13,608) | $ (5,334) | $ (20,982) | $ (7,830) |
Undistributed net loss available to nonvested restricted stockholders and holders of convertible preferred stock | 0 | (234) | 0 | (309) |
Undistributed net loss available to common stockholders | $ (13,608) | $ (5,568) | $ (20,982) | $ (8,139) |
Weighted average common shares outstanding - basic (in shares) | 18,723,957 | 18,106,151 | 19,243,707 | 18,034,658 |
Weighted average common shares outstanding—diluted (in shares) | 18,723,957 | 18,106,151 | 19,243,707 | 18,034,658 |
Earnings Per Share, Basic, Undistributed (in USD per share) | $ (0.73) | $ (0.31) | $ (1.09) | $ (0.45) |
Earnings Per Share, Diluted, Undistributed (in USD per share) | $ (0.73) | $ (0.31) | $ (1.09) | $ (0.45) |
Stock Options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Shares issuable under stock options (in shares) | 0 | 0 | 0 | 0 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 410,907 | 481,429 | 410,907 | 487,088 |
Cumulative Preferred Stock | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 444,849 | 0 | 444,849 | |
Performance-Based Restricted Stock Units (PBRSUs) | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 501,141 | 498,210 | 469,297 | 437,211 |
Preferred Stock (Details)
Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions | Aug. 26, 2022 | Oct. 02, 2017 | Dec. 31, 2022 | Jun. 30, 2022 |
Auction Market Preferred Securities, Stock Series [Line Items] | ||||
Preferred Stock, Shares Authorized (in shares) | 500,000 | 500,000 | ||
Preferred stock, par value (in US$ per share) | $ 1 | $ 1 | ||
Preferred stock, issued (in shares) | 0 | |||
Preferred Stock, Shares Outstanding | 0 | |||
Preferred Class A | ||||
Auction Market Preferred Securities, Stock Series [Line Items] | ||||
Preferred Stock, Shares Authorized (in shares) | 21,000 | 21,000 | ||
Preferred stock, issued (in shares) | 14,700 | |||
Preferred Stock, Shares Outstanding | 0 | 14,700 | ||
Series A Preferred Stock | ||||
Auction Market Preferred Securities, Stock Series [Line Items] | ||||
Preferred stock, issued (in shares) | 1,736 | |||
Preferred Stock, Conversion Price Per Share | $ 38.32 | |||
Preferred Stock, Number Of Shares Converted | 12,964 | |||
Convertible Preferred Stock, Shares Issued upon Conversion | 399,208 | |||
Preferred Stock, Shares Withheld Due To Pending Satisfaction | 914 | |||
Gain (Loss) Related to Referred Stock Settlement | $ 1.9 |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2022 | |
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 132,692 | $ 118,445 | $ 254,073 | $ 226,807 | |
Receivables from contracts with customers | $ 49,132 | $ 49,132 | $ 44,219 | ||
Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 100% | 100% | 100% | 100% | |
Product | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 131,492 | $ 117,369 | $ 251,653 | $ 225,278 | |
Product | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 99.10% | 99.10% | 99% | 99.30% | |
Coffee (Roasted) | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 82,725 | $ 75,506 | $ 161,019 | $ 146,104 | |
Coffee (Roasted) | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 62.30% | 63.80% | 63.40% | 64.40% | |
Tea (Iced & Hot) | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 26,686 | $ 22,891 | $ 47,632 | $ 41,928 | |
Tea (Iced & Hot) | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 20.20% | 19.30% | 18.70% | 18.50% | |
Culinary | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 16,372 | $ 13,913 | $ 31,269 | $ 26,988 | |
Culinary | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 12.30% | 11.70% | 12.30% | 11.90% | |
Spice | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 5,709 | $ 5,059 | $ 11,733 | $ 10,258 | |
Spice | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 4.30% | 4.30% | 4.60% | 4.50% | |
Fuel Surcharge | |||||
Disaggregation of Revenue [Line Items] | |||||
Net Sales | $ 1,200 | $ 1,076 | $ 2,420 | $ 1,529 | |
Fuel Surcharge | Revenue Benchmark | Product Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
% of total | 0.90% | 0.90% | 1% | 0.70% |
Commitments and Contingencies (
Commitments and Contingencies (Details) - Inventories $ in Millions | Dec. 31, 2022 USD ($) |
Coffee | |
Contractual Obligations | |
Purchase Obligation, Due in Next Twelve Months | $ 76.2 |
Other Inventory | |
Contractual Obligations | |
Purchase Obligation, Due in Next Twelve Months | $ 14.6 |
Sales of Assets (Details)
Sales of Assets (Details) | 3 Months Ended |
Dec. 31, 2022 USD ($) | |
Portland, Oregon | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Sales Price | $ 1,990,000 |
Net Proceeds | 1,880,000 |
Gain on Sale | 1,770,000 |
San Diego, California | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Sales Price | 7,574,000 |
Net Proceeds | 7,169,000 |
Gain on Sale | 6,425,000 |
Fresno, California | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Sales Price | 760,000 |
Net Proceeds | 716,000 |
Gain on Sale | $ 648,000 |